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   Cystic	   fibrosis	   (CF)	   is	   the	   most	   common	   lethal	   hereditary	   disease.	   CF	   is	  caused	  by	  recessive	  mutations	   in	  the	  Cystic	  Fibrosis	  Transmembrane	  Conductance	  Regulator	   (CFTR)	   gene	   and	   is	   associated	   with	  multi-­‐organ	   defects	   resulting	   from	  improper	  ion	  transport	  across	  epithelial	  membranes.	  Chronic	  lung	  infection	  by	  the	  environmentally	   ubiquitous	   opportunistic	   human	   pathogen	   Pseudomonas	  
aeruginosa	  and	  the	  subsequent	  hyperinflammation	  that	  occurs	  as	  the	  host	  immune	  system	   combats	   the	   bacterium	   cause	   substantial	   morbidity	   and	   mortality	   in	   CF.	  Despite	   numerous	   studies	   that	   have	   sought	   to	   elucidate	   the	   role	   of	   CFTR	   in	   the	  innate	   immune	   response,	   the	   links	   between	   CFTR,	   innate	   immunity,	   and	   P.	  
aeruginosa	  infection	  remain	  unclear.	  The	  present	  work	  highlights	  the	  zebrafish	  as	  a	  powerful	   model	   organism	   for	   human	   infectious	   disease.	   Zebrafish	   embryos	   with	  reduced	  expression	  of	  the	  cftr	  gene	  (Cftr	  morphants)	  exhibited	  reduced	  respiratory	  burst	  response	  and	  directed	  neutrophil	  migration,	  supporting	  a	  connection	  between	  
cftr	  and	  the	  innate	  immune	  response.	  	  Cftr	  morphants	  were	  also	  found	  to	  display	  a	  
	  	  
	   iv	  
significant	  iron	  deficiency	  (ID)	  compared	  to	  control	  embryos,	  a	  symptom	  commonly	  diagnosed	  in	  CF	  patients.	  Cftr	  morphants	  were	  infected	  with	  P.	  aeruginosa	  or	  other	  bacterial	   species	   that	   are	   commonly	   associated	   with	   infections	   in	   CF	   patients,	  including	   Burkholderia	   cenocepacia,	   Haemophilus	   influenzae,	   and	   Staphylococcus	  
aureus.	   Intriguingly,	   the	   bacterial	   burden	   of	   P.	   aeruginosa	   was	   found	   to	   be	  significantly	  higher	  in	  zebrafish	  Cftr	  morphants	  than	  in	  controls,	  a	  phenomenon	  that	  was	  not	  observed	  with	  any	  of	   the	  other	  bacterial	   species	  examined.	   	  The	  bacterial	  burden	   in	   Cftr	   morphants	   infected	   with	   a	   P.	   aeruginosa	   LasR	   mutant,	   a	   quorum	  sensing	  (QS)-­‐deficient	  strain,	  was	  comparable	  to	  that	  in	  control	  fish	  indicating	  that	  the	   regulation	   of	   virulence	   factors	   through	   QS	   is	   required	   for	   enhancement	   of	  infection	   in	   the	   absence	   of	   Cftr.	   Cftr	   morphants	   were	   then	   challenged	   with	   P.	  
aeruginosa	  mutants	  defective	  in	  the	  expression	  of	  QS	  regulated	  virulence	  factors.	  A	  mutant	  defective	  in	  the	  production	  of	  Exotoxin	  A	  (ETA)	  resulted	  in	  similar	  bacterial	  clearance	  in	  both	  the	  Cftr	  morphant	  and	  control	  embryos.	  The	  reduction	  in	  directed	  neutrophil	  migration	  to	  a	  P.	  aeruginosa	  infection	  was	  also	  restored	  when	  zebrafish	  embryos	  were	   challenged	  with	   the	   ETA	  mutant.	   Taken	   together,	   these	   data	   point	  towards	  a	  possible	  explanation	  for	  the	  specificity	  between	  P.	  aeruginosa	  and	  CFTR.	  The	   zebrafish	   system	  provides	   a	  multitude	   of	   advantages	   for	   studying	   the	   unique	  pathophysiology	   resulting	   from	   defective	   expression	   of	   CFTR,	   investigating	   the	  pathogenesis	  of	  P.	  aeruginosa	  and	  elucidating	  the	  role	  that	  the	  innate	  system	  plays	  in	   the	  host	  response	   to	  acute	  bacterial	   infections	  commonly	  associated	  with	  cystic	  fibrosis.
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CHAPTER	  1	  
INTRODUCTION	  
1.1.	  Cystic	  fibrosis	  
1.1.1.	  History	   	  	   Cystic	   fibrosis	   (CF)	   is	   recognized	   as	   the	   most	   common	   lethal	   hereditary	  disease	   among	   Caucasian	   individuals	   (23).	   Approximately	   40,000	   people	   in	   the	  United	   States,	   and	   an	   additional	   40,000	   throughout	   the	   world,	   have	   CF,	   and	   an	  estimated	   10	  million	   Americans	   carry	   a	  mutation	   in	   the	   gene	   responsible	   for	   the	  disease.	  The	   syndrome	  was	   first	   characterized	   in	  1938	  when	  Dr.	  Dorothy	  Andersen	  described	  cystic	  fibrosis	  of	  the	  pancreas	  and	  for	  the	  first	  time	  distinguished	  CF	  from	  celiac	  disease	  and	  other	  gastrointestinal	  diseases	  thought	  to	  be	  at	  fault	  (23).	  It	  was	  not	  until	  1949,	  however,	  that	  a	  simple	  observation	  by	  a	  perceptive	  pediatrician	  at	  a	  New	  York	  children’s	  hospital	  revealed	  one	  symptom	  of	  the	  disease	  that,	  not	  only	  is	  still	  widely	  used	  as	  a	  diagnostic,	  but	   for	   the	   first	   time	  pointed	  researchers	   toward	  the	   cause	   of	   the	   collection	   of	   symptoms	   associated	   with	   this	   newly	   discovered	  disorder.	  By	  identifying	  a	  subset	  of	  patients	  suffering	  from	  severe	  heat	  stroke	  during	  a	   heat	   wave	   that	   summer,	   he	   speculated	   that	   these	   patients	   were	   dehydrating	  because	  of	  a	  higher	  than	  normal	  loss	  of	  salt.	  He	  concluded	  that	  children	  with	  what	  we	  now	  know	  as	  CF	  had	  abnormally	  high,	  as	  much	  as	  three	  to	  five	  times	  higher,	  salt	  in	   their	   sweat	   than	   normal	   children	   (115).	   Over	   the	   next	   decade,	   researchers	  concluded	  that	  the	  high	  salt	   in	  the	  sweat	  of	  CF	  patients	  was	  a	  result	  of	  a	   failure	  to	  reabsorb	  NaCl	  in	  the	  sweat	  duct	  prior	  to	  secretion.	  The	  diagnoses	  at	  infancy	  of	  sweat	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concentrations	  higher	  than	  60	  mM	  remains	  to	  this	  day	  as	  a	  confirmative	  diagnosis	  of	  CF.	   In	   1989,	   the	   defective	   gene	   responsible	   for	   cystic	   fibrosis	   was	   cloned	   and	  identified	   as	   the	   Cystic	   Fibrosis	   Transmembrane	   Conductance	   Regulator	   (CFTR)	  (63).	  CFTR	  encodes	  an	  ATP	  dependant	  cAMP	  regulated	  chloride	  ion	  channel	  that	  is	  expressed	  by	  virtually	  all	  epithelial	  cells	  and	  is	  responsible	  for	  chloride	  conductance	  and	  ultimately	  the	  regulation	  of	  NaCl	  secretion	  from	  the	  cells	  (28).	  	  Since	   1989,	   nearly	   2000	   different	   mutations	   in	   CTFR	   have	   been	   identified	  (126).	   About	   one	   half	   of	   all	   CF	   cases,	   however,	   result	   from	   the	   deletion	   of	   a	  phenylalanine	   residue	   from	   amino	   acid	   position	   508	   (ΔF508)	   (105).	   Among	   the	  thousands	   of	   mutations	   that	   have	   been	   identified,	   those	   that	   have	   been	  characterized	  have	  been	  grouped	  into	  five	  classes	  of	  mutations,	  based	  on	  the	  result	  of	  the	  mutation.	  The	  ΔF508	  mutation	  is	  considered	  a	  class	  II	  mutation	  and	  results	  in	  a	   mis-­‐folding	   of	   the	   protein	   and	   subsequent	   degradation	   at	   the	   endoplasmic	  reticulum.	  Other	  mutations	  may	  result	  in	  a	  protein	  that	  is	  either	  poorly	  regulated	  or	  completely	  dysfunctional,	  a	  protein	  that	  is	  expressed	  at	  lower	  levels	  than	  normal,	  or	  a	   transcript	   that	   simply	   cannot	   be	   translated.	   Regardless	   of	   the	   specific	  mutation,	  people	   carrying	   two	   defective	   alleles	   express	   a	   classic	   group	   of	   respiratory	   and	  gastrointestinal	  symptoms.	  
1.1.2.	  Pathophysiology	  of	  cystic	  fibrosis	  
	   1.1.2.1.	  Digestive	  System	  CFTR	   is	   highly	   expressed	   in	   the	   epithelial	   cells	   lining	   the	   intestine	   and	   is	  responsible	   for	   hydrating	   the	   mucus	   by	   secreting	   water	   into	   the	   intestine.	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Approximately	  10-­‐15%	  of	   infants	  with	  CF	  will	  die	   soon	  after	  birth	  due	   to	  a	  bowel	  obstruction	   called	   meconium	   ileus,	   and	   obstruction	   of	   the	   small	   intestine	   is	   a	  recurring	  problem	  throughout	   the	   lives	  of	  most	  people	  with	  CF	  (115).	   	  Among	  the	  myriad	   of	   symptoms	   associated	   with	   CF,	   progressive	   pancreatic	   failure	   over	   the	  course	  of	  the	  patient’s	  life	  is	  a	  grave	  concern	  for	  CF	  researchers.	  CFTR	  is	  expressed	  in	   the	  cells	   lining	   the	  pancreatic	  ducts	  and	   is	   responsible	   for	  hydrating	   the	  mucus	  that	  aids	  the	  secretion	  of	  pancreatic	  fluid	  and	  enzymes	  into	  the	  small	  intestine.	  As	  a	  result	   of	   impaction	   of	   these	   ducts	   by	   viscid	   dehydrated	   mucus,	   malnutrition	   is	  common	  and	  specific	  dietary	  regimens	  and	  vitamin	  supplements	  are	  necessary.	  The	  pancreatic	  symptoms	  experienced	  by	  CF	  patients	  are	  progressive	  and	  failure	  of	  the	  organ	   over	   the	   course	   of	   the	   patient’s	   life	   ultimately	   results	   in	   reduced	   levels	   of	  insulin	   and	   glucagon	   in	   circulation	   and	   an	   almost	   total	   inability	   to	   absorb	  carbohydrates	  and	  fat	  soluble	  vitamins	  (57).	  	   1.1.2.2.	  Iron	  deficiency	  in	  cystic	  fibrosis	  Iron	  deficiency	  (ID)	  has	   long	  been	  associated	  with	   the	  general	  malnutrition	  caused	   by	   the	   reduced	   pancreatic	   function	   and	   poor	   nutrient	   uptake	   in	   cystic	  fibrosis	   (6).	  Many	  of	   the	  nutritional	  deficiencies	   linked	   to	  CF	  have	  been	  overcome	  with	  innovative	  and	  aggressive	  therapies	  over	  the	  past	  few	  decades.	  Iron,	  however,	  remains	  a	  major	  concern	  and	  the	  deficiency	  experienced	  by	  a	  large	  percentage	  of	  CF	  patients	   that	   are	   not	   responsive	   to	   these	   therapies	   has	   led	   researchers	   to	   believe	  that	  the	  ID	  experienced	  in	  CF	  may	  in	  fact	  be	  multifaceted	  and	  not	  as	  simple	  as	  once	  believed	  (121).	  The	  clinical	  data	  available	  varies	  greatly	  depending	  on	  the	  age	  and	  
	  	  
	   4	  
location	  of	  the	  subjects	  studied,	  but	  it	  is	  clear	  that	  30	  –	  60%	  of	  CF	  patients	  are	  in	  fact	  ID,	  depending	  on	  the	  age	  of	  the	  individual	  (1,	  34,	  41,	  46,	  109,	  110,	  121,	  153).	  A	  study	  by	  von	  Drygalski	  and	  colleagues	   found	  a	  high	  prevalence	  of	  anemia	   in	  CF	  patients	  that	   increased	   with	   age.	   This	   led	   the	   team	   to	   conclude	   that	   as	   the	   health	   of	   the	  individual	  declined	  over	  the	  course	  of	  his	  or	  her	  life,	  as	  a	  result	  of	  respiratory	  failure	  and	  diminishing	  pancreatic	  function,	  that	  the	  incidence	  of	  anemia	  and,	  in	  more	  than	  60%	   of	   the	   cases,	   a	   diagnosed	   iron	   deficiency,	   became	  more	   prevalent	   (153).	   	   A	  study	  of	  71	  CF	  patients	  at	  Seacroft	  Hospital	   in	  Leeds,	  UK,	  showed	  that	  62%	  of	   the	  patients	  age	  16	  to	  28	  were	  functionally	  iron	  deficient,	  twenty-­‐three	  percent	  of	  the	  ID	  patients	  were	   also	   diagnosed	   as	   anemic	   (109).	   A	   group	   led	   by	   Dr.	   David	   Reid,	   in	  Melbourne	  found	  that	  of	  30	  patients	  from	  21	  –	  36	  years	  old,	  72%	  were	  diagnosed	  as	  ID	  determined	  by	  both	  transferrin	  saturation,	  a	  standard	  clinical	  measurement	   for	  ID,	  and	  by	  a	  serum	  iron	  assay	  (121).	  Unfortunately,	  as	  is	  often	  the	  case	  with	  clinical	  data,	   retrospective	   studies	   are	   often	   incomplete	   making	   the	   data	   difficult	   to	  interpret.	  There	  is	  a	  growing	  pool	  of	  clinical	  data	  that	  suggests	  sputum	  from	  cystic	  fibrosis	  patients	  contains	  abnormally	  high	  levels	  of	  iron	  (46,	  119,	  136,	  137).	  While	  many	  of	  these	  studies	  effectively	  showed	  a	  significantly	  higher	  concentration	  of	  iron	  in	  the	  CF	  lung,	  the	  data	  have	  been	  a	  matter	  of	  contention	  among	  some	  researchers	  who	   insist	   that	   the	   techniques	  used	   to	  measure	   iron	  may	   in	   fact	   be	   an	   inaccurate	  measure	   of	   the	   total	   available	   iron	   in	   the	   lung	   (64)	   and	   the	   limitations	   of	   clinical	  reports	  which	  cannot	  provide	  a	   suitable	   control	   group	  may	  bias	   the	   results	  of	   the	  studies.	  Retrospective	   studies	   of	   patient	   charts	   and	  prospective	   studies	  have	  both	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established	  a	  significant	  iron	  deficiency	  and	  anemia	  in	  CF	  patients,	  including	  studies	  that	   found	   higher	   iron	   levels	   in	   sputum	   samples.	   Recently,	   Gifford	   and	   colleagues	  reported	   a	   prospective	   study	   of	   39	   CF	   patients	   at	   Dartmouth-­‐Hitchcock	   Medical	  Center	   who	   were	   chronically	   infected	   with	   P.	   aeruginosa	   (46).	   In	   this	   study,	   the	  authors	   found	  a	  significant	  correlation	  between	  the	  ID	  state	  of	   the	  patient	  and	  the	  clinical	  worsening	  of	  lung	  function.	  Contrary	  to	  the	  conclusions	  of	  Reid,	  et	  al.	  (120),	  Gifford	  and	  colleagues	  found	  no	  significant	  link	  between	  the	  iron	  state	  in	  the	  CF	  lung	  and	  the	  ID	  state	  in	  the	  patient	  overall,	  supporting	  the	  notion	  that	  the	  increased	  iron	  in	  the	  lung	  may	  be	  associated	  with	  the	  presence	  of	  the	  bacteria	  (46).	  
1.1.2.3	  Respiratory	  system	  By	   far	   the	   most	   severe	   symptoms	   associated	   with	   cystic	   fibrosis,	   indeed	  those	  that	  are	  responsible	  for	  the	  majority	  of	  the	  morbidity	  and	  mortality	  in	  CF,	  are	  those	  of	  the	  respiratory	  tract.	  Many	  pathology	  studies	  have	  shown	  that	  the	  CF	  lung	  looks	   relatively	   normal	   at	   birth.	   Soon	   after,	   however,	   the	   defect	   in	   CFTR	   has	   dire	  consequences	   on	   the	   hydration	   of	   the	   mucus	   at	   the	   surface	   of	   the	   respiratory	  epithelium	  (80).	  This	  hydration	  defect	  results	  in	  an	  airway	  surface	  liquid	  (ASL)	  that	  is	   abnormally	   thick	   and	   viscid	   and	   devoid	   of	   salts.	   Eventually,	   impacted	   mucus	  blocks	   the	   alveolar	   ducts	   resulting	   in	   decreased	   pulmonary	   function	   and	  perpetuating	   the	   dehydration	   of	   the	   ASL	   (10).	   The	   advent	   of	  modern	   therapeutic	  drugs	   such	   as	   mucus	   thinners	   and	   bronchodilators	   has	   reduced	   some	   of	   the	  respiratory	   distress	   of	   CF	   patients	   by	   clearing	   their	   airway	   and	   removing	   the	  impacted	  mucus	  (117).	  Respiratory	  problems	  persist	  however,	  and	  ultimately	  80	  –	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90%	  percent	  of	  CF	  patients	  will	  succumb	  to	  respiratory	  failure	  resulting	  from	  tissue	  destruction	  brought	  on	  by	  an	  importunate,	  yet	  ineffective,	  inflammatory	  response	  to	  chronic	   bacterial	   infections	   of	   the	   lung	   (80).	   For	   decades,	   it	   was	   accepted	   that	  successive	  bacterial	  infections	  of	  CF	  children	  were	  simply	  the	  result	  of	  thick	  mucus	  lining	   the	   respiratory	   tract	   and	   providing	   an	   excellent	   growth	   medium	   for	   the	  bacteria.	   Recently,	   however,	   certain	   trends	   have	   been	   emerging	   in	   the	   timeline	   of	  these	   infections	   and	   the	   particular	   pathogens	   that	   predominate.	   There	   is	   now	   a	  great	  deal	  of	  evidence	  that	  suggests	  that	  there	  may	  be	  a	  more	  specific	  relationship	  between	  the	  molecular	  impacts	  of	  a	  defective	  chloride	  channel	  and	  the	  predominant	  pathogens	  found	  in	  the	  majority	  of	  CF	  patients.	  
1.1.3.	  Bacterial	  infections	  of	  the	  CF	  Lung	  Bacterial	   infections	   are	   common	   and	   usually	   result	   in	   chronic	   persistent	  colonization	   as	   a	   consequence	   of	   the	   inability	   of	   the	   host’s	   immune	   system	   to	  properly	   eradicate	   these	   infections.	   A	   wide	   variety	   of	   pathogens	   have	   been	  recovered	   from	   the	   lungs	   of	   CF	   patients,	   and	   the	   severity	   of	   the	   infections	   and	  indeed	   the	   pathogen	   itself	   are	   often	   closely	   correlated	   to	   the	   age	   of	   the	   patient.	  Typically,	   infections	   in	   early	   childhood	   are	   caused	   by	   Staphylococcus	   aureus	   and	  
Haemophilus	  influenzae	  and	  often	  recur	  throughout	  childhood	  and	  adolescence	  and	  are	   usually	   easily	   treated	   with	   antibiotics	   (10,	   80).	   Infections	   by	   the	   bacterium	  
Stenotrophomonas	  maltophilia	  have	  been	  increasing	  in	  prevalence	  over	  the	  past	  few	  decades,	  most	   frequently	   infecting	  CF	  patients	   in	   the	   teen	   years.	   These	   infections,	  however,	   are	   poorly	   studied	   and	   their	   impact	   on	   clinical	   outcome	   is	   still	   unclear	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(23).	   Recently,	   infections	   by	   the	   Burkholderia	   cepacia	   complex	   of	   opportunistic	  pathogens	   have	   become	   a	   great	   concern	   to	   clinicians	   with	   CF	   patients	   as	   studies	  have	  shown	  that	   these	   infections	  result	   in	  extremely	  poor	  clinical	  outcomes	  and	  a	  dramatic	   increase	   in	  mortality	   (72).	   Lung	   transplant	   recipients	   that	  were	  positive	  for	  B.	   cenocepacia	   (B.	   cepacia	   genomovar	   III)	  have	  a	  dramatically	  higher	  mortality	  rate	   after	   transplantation,	   prompting	   many	   centers	   to	   remove	   culture	   positive	  individuals	  from	  transplant	  lists	  (26).	  Despite	  the	  wide	  array	  of	  bacterial	  pathogens,	  as	  well	  as	  viral	  and	  fungal	  pathogens,	  which	  will	  not	  be	  discussed	  here,	  one	  species	  of	  bacteria	  is	  by	  far	  the	  most	  common	  and	  most	  difficult	  to	  eradicate	  once	  infection	  has	   been	   established.	   Pseudomonas	   aeruginosa	   has	   been	   recognized	   as	   the	   most	  important	   CF	   pathogen	   since	   the	   1960s	   and	   today	   is	   responsible	   for	   chronic	  respiratory	  infections	  in	  at	  least	  80%	  of	  CF	  patients.	  	  
1.1.4.	  Pseudomonas	  aeruginosa	  
Pseudomonas	  aeruginosa	  is	  a	  Gram-­‐negative	  opportunistic	  pathogen	  of	  plants	  and	   animals	   (156).	   The	   capacity	   of	   this	   bacterium	   to	  metabolize	   a	   wide	   array	   of	  carbon	   sources	   and	   its	   ability	   to	   grow	   at	   a	   range	   of	   temperatures	   means	   that	   P.	  
aeruginosa	   can	   be	   found	   in	   nearly	   all	   environments.	   Although	  most	   people	   come	  into	   contact	   with	   this	   ubiquitous	   microbe	   practically	   every	   day,	   infections	   in	  otherwise	   healthy	   individuals	   are	   nearly	   unheard	   of.	   Underlying	   conditions	   that	  result	   in	   a	   compromise	   of	   the	   host’s	   immune	   defenses	   are	   nearly	   always	   present	  when	   an	   infection	   with	   P.	   aeruginosa	   is	   established	   (156).	   P.	   aeruginosa	   is	  responsible	  for	  approximately	  10%	  of	  all	  nosocomial	  infections,	  making	  it	  the	  fourth	  
	  	  
	   8	  
most	   commonly	   isolated	   pathogen	   in	   hospital	   settings	   (143).	   P.	   aeruginosa	  expresses	   multiple	   drug	   efflux	   pumps	   and	   enzymes	   targeted	   at	   many	   common	  antibiotics.	   This	   coupled	   with	   the	   fact	   that	   P.	   aeruginosa	   has	   one	   of	   the	   most	  impermeable	  outer	  membranes,	   roughly	  100	  times	  more	   impermeable	   than	  E.	  coli	  gives	   this	   pathogen	   a	   high	   level	   of	   intrinsic	   antibiotic	   resistance	   and	   makes	  infections	  very	  difficult	  to	  treat	  (139).	  The	  almost	  uniquely	  high	  resistance	  to	  many	  of	  our	  modern	  antibiotic	  treatments	  and	  the	  myriad	  of	  virulence	  factors	  encoded	  in	  its	  genome	  make	  P.	  aeruginosa	  a	  major	  concern	  for	  patients	  in	  intensive	  care	  units,	  particularly	  those	  with	  implanted	  devices	  such	  as	  catheters.	  	  	   1.1.4.1.	  P.	  aeruginosa	  infections	  in	  CF	  Although	  many	  pathogens	  are	   responsible	   for	   infections	   in	  CF	  patients	   and	  various	  species	  of	  bacteria,	  virus	  and	  fungi	  are	  all	  problematic	  for	  these	  individuals,	  infection	   by	   P.	   aeruginosa	   ultimately	   predominates	   and	   acute	   pneumonia	   rapidly	  evolves	  into	  a	  chronic,	  persistent	  infection	  of	  the	  airway	  that	  is	  nearly	  impossible	  to	  eradicate	  (49).	  After	  nearly	  60	  years	  of	  research,	  the	  most	  puzzling	  aspect	  of	  cystic	  fibrosis,	   one	   that	   has	   yet	   to	   be	   sufficiently	   elucidated,	   is	   why	   this	   particular	  population	   of	   people	   is	   sensitive	   to	   infection	   by	   this	   particular	   microbe.	   	   P.	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1.1.4.2.	  Virulence	  factors	  of	  P.	  aeruginosa	  
1.1.4.2.1.	  Type	  III	  Secretion	  System	  The	   Type	   III	   Secretion	   System	   (T3SS)	   of	   Gram-­‐negative	   bacteria	   facilitates	  the	   direct	   transfer	   of	   toxins	   into	   the	   cytoplasm	   of	   eukaryotic	   cells	   (14,	   147).	   P.	  
aeruginosa	   encodes	   four	   exotoxins	   that	   have	   been	   shown	   to	   be	   delivered	   via	   the	  T3SS	   apparatus	   (14).	   Studies	   have	   documented	   the	   significance	   of	   the	   T3SS	   of	   P.	  
aeruginosa,	   and	   the	   exoenzymes	   delivered	   through	   it,	   in	   the	   pathogenesis	   of	  infection	   of	   humans,	   plants,	   insects,	   nematodes	   and	   most	   recently	   infection	   of	  zebrafish	  embryos	  (7,	  12,	  147).	  Table	  1.1.	  Virulence	  factors	  of	  P.	  aeruginosa	  
	  
1.1.4.2.2.	  Quorum	  sensing	  Since	  the	  first	  quorum	  sensing	  (QS)	  system	  was	  described	  in	  1979,	  we	  have	  learned	  a	  great	  deal	  about	  how	  important	  cell-­‐to-­‐cell	  communication	  is	  to	  bacterial	  survival	   (93).	   The	   LuxR	   regulatory	   network	   that	   controls	   genes	   required	   for	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bioluminescence	   in	   the	   endosymbiotic	   bacterium	  Vibrio	   fischeri	   is	   by	   far	   the	  most	  thoroughly	  characterized	  QS	  system	  of	  any	  bacterial	  species.	  Since	  the	  identification	  of	   the	  V.	   fischeri	   LuxR	   system,	   similar	   QS	   networks	   have	   been	   identified	   in	  many	  other	   species	   including	  P.	   aeruginosa	   and	  B.	   cenocepacia	   (71,	   155).	  Unfortunately,	  while	   the	   QS	   network	   of	   V.	   fischeri	   controls	   systems	   that	   are	   beneficial	   for	   the	  survival	   of	   its	   host,	   the	   QS	   system	   of	  P.	   aeruginosa	   and	   other	   bacterial	   species	   is	  responsible	   for	   the	   regulation	   of	   genes	   that	   permit	   invasion	   and	   pathogenicity	   in	  their	   host	   (116).	   Many	   of	   the	   virulence	   factors	   P.	   aeruginosa	   releases	   during	  infection	  are	  primarily	  regulated	  through	  the	  LasR	  QS	  network	  (Figure	  1.1),	   the	  P.	  
aeruginosa	  homologue	  of	  the	  LuxR	  system	  in	  V.	  fischeri.	  The	  sophisticated	  regulatory	  network	   that	  ultimately	   results	   in	   the	   transcription	  of	  numerous	  virulence	   factors	  begins	   with	   the	   production	   and	   secretion	   of	   two	   signal	   molecules,	   3-­‐oxo-­‐C12-­‐Homoserine	   Lactone	   (HSL)	   and	   C4-­‐HSL	   (37).	   When	   the	   concentration	   of	   these	  molecules	  builds	   to	   a	   sufficient	   threshold,	   a	   result	   of	   cell	   density,	   the	  Las	   and	  Rhl	  transcriptional	   regulators	   are	   activated	   and	   begin	   to	   induce	   the	   expression	   of	  multiple	  downstream	  factors,	  and	  are	  ultimately	  responsible	  for	  the	  transition	  into	  biofilm	  growth	  in	  P.	  aeruginosa	  (102).	  	  Figure	   1.1	   outlines	   the	   hierarchical	   QS	   gene	   regulation	   pathway	   of	   P.	  
aeruginosa.	   While	   the	   LasR/RhlR	   QS	   system	   of	   P.	   aeruginosa	   is	   the	   best	  characterized	   of	   any	   pathogen,	   recent	   studies	   showing	   RhlR	   regulation	   of	   factors	  once	   thought	   to	   be	   under	   strict	   control	   of	   LasR	   have	   revealed	   surprising	   new	  evidence	   that	   the	   pathway	  may	   in	   fact	   be	  more	   complex	   than	   once	   thought	   (27).	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Despite	  the	  controversy	  that	  exists	  over	  the	  regulation	  hierarchy	  in	  the	  LasR/RhlR	  QS	   system,	   it	   is	   clear	   that	   this	   pathway,	   and	   the	   downstream	   products	   of	   it,	   is	  immensely	  important	  in	  P.	  aeruginosa	  infections	  in	  CF.	  Researchers	   have	   successfully	   isolated	   the	   Alkaline	   Metalloprotease,	  Elastases	  and	  Exotoxin	  A,	  along	  with	  the	  HSL	  signals	  that	  induced	  their	  expression,	  from	   the	   sputum	  of	   CF	   patients	   chronically	   infected	  with	  P.	   aeruginosa	   (37,	   138).	  The	  LasR/RhlR	  QS	  system	  and	  the	  factors	  it	  regulates	  are	  ultimately	  responsible	  for	  and	   required	   for	   the	   transition	   from	   free-­‐swimming	   planktonic	   bacteria	   to	   a	  complex	   multi-­‐cellular	   community	   called	   a	   biofilm	   (24).	   Paradoxically,	   a	   recent	  study	  has	  shown	  that	  during	  chronic	  infections	  in	  the	  CF	  lung	  later	  in	  the	  course	  of	  infection,	   inactivating	   mutations	   in	   LasR	   are	   common	   because	   growth	   conditions	  are	   actually	   selective	   for	   LasR	   mutants	   (54).	   The	   study	   revealed	   that	   among	   P.	  
aeruginosa	   isolates	   from	  166	  CF	  patients,	  31%	  of	   the	   isolates	  were	  LasR	  mutants.	  The	   authors	   stated	   that	   the	   expression	  of	   downstream	  effectors	   and	   the	   ability	   of	  the	  mutants	   to	   grow	   as	   biofilms	   remained	   intact	   despite	   the	   inactivation	   of	   LasR,	  leading	  them	  to	  speculate	  that	  regulation	  of	  these	  genes	  has	  been	  “uncoupled”	  from	  the	  LasR	  pathway.	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  Figure	   1.1.	   The	   LasR	   Quorum	   Sensing	   System	   of	   P.	   aeruginosa.	  Adapted	   from:	  E.	  C.	  Pesci,	   J.	  P.	  Pearson,	  P.	  C.	  Seed	  and	  B	  H.	   Iglewski.	  1997.	   Regulation	   of	   las	   and	   rhl	   Quorum	   Sensing	   in	   Pseudomonas	  
aeruginosa.	  Journal	  of	  Bacteriology	  179(10)	  3127–3132	  	  
1.1.4.2.3.	  Iron	  regulated	  virulence	  factors	  	  
1.1.4.2.3.1.	  Exotoxin	  A	  	   Exotoxin	  A	  (ETA)	  of	  P.	  aeruginosa	  is	  an	  ADP-­‐ribosyl	  transferase	  that	  is	  highly	  toxic	  to	  eukaryotic	  cells	  and	  considered	  the	  most	  toxic	  virulence	  factor	  produced	  by	  the	  bacterium	  (56,	  77).	  First	  identified	  in	  1966	  as	  the	  P.	  aeruginosa	  lethal	  toxin,	  Lui	  found	   that	   the	   exoproducts	   produced	   during	   cell	   growth	  were	   lethal	   to	  mice	   and	  caused	   severe	   skin	   lesions	   on	   rabbits	   (77).	   Ten	   years	   later,	   Iglewski	   and	   Kabat	  described	  the	  mechanism	  of	  ETAs	  toxicity	  and	  showed	  that	   the	  protein	  toxin	   is	  an	  ADP-­‐ribosylase	   and	   functions	   to	   irreversibly	  modify	   elongation	   factor-­‐2	   (EF-­‐2)	   of	  eukaryotic	   cells	   halting	   protein	   synthesis	   and	   inducing	   apoptosis	   (56).	   ETA	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  Figure	   1.2.	   Iron	   Regulated	   Virulence	   Network	   of	   P.	   aeruginosa.	  Adapted	   from:	   Vasil,	   M.L.	   and	   Ochsner,	   U.A.	   1999.	   The	   response	   of	  
Pseudomonas	  aeruginosa	  to	  iron:	  genetics,	  biochemistry	  and	  virulence.	  Molecular	  Microbiology	  34(3):399-­‐413	  
	  
	   	   	   	   1.1.4.2.3.2.	  Siderophores	  
	   When	   iron	   is	   scarce,	   P.	   aeruginosa	   deploys	   two	   potent	   iron	   chelating	  siderophores,	   pyoverdine	   and	   pyochelin	   (116).	   These	   siderophores	   scavenge	   free	  iron	  from	  the	  environment	  and	  are	  so	  efficient	  that	  they	  are	  capable	  of	  sequestering	  iron	   from	   the	   iron	   binding	   proteins,	   such	   as	   transferrins,	   of	   their	   host	   during	  infection	   and	   delivering	   the	   iron	   to	   the	   bacterium	   through	   cell	   surface	   receptors.	  Pyoverdine	   and	   its	   specific	   receptor	   also	   serve	   a	   gene	   regulation	   function.	  When	  unbound	   pyoverdine	   interacts	   with	   the	   receptor,	   the	   sigma	   factor	   PvdS	   is	   up-­‐
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regulated.	   PvdS,	   in	   turn,	   induces	   the	   expression	   of	   pyoverdine	   and	   the	   highly	  cytotoxic	  Exotoxin	  A	  and	  Serine	  Protease	  IV	  (68).	  The	  regulation	  of	  these	  virulence	  genes	   through	   iron	   availability	   is	   yet	   another	   example	   of	   how	   P.	   aeruginosa	   is	  extremely	  well	  adapted	  to	  acquiring	  essential	  nutrients	  from	  its	  environment	  by	  any	  means	  necessary.	  	  
1.1.4.2.4.	  Elastases	  and	  Proteases	  
	   The	  Elastase	  LasB,	  the	  Serine	  Protease	  LasA	  and	  the	  Alkaline	  Metalloprotease	  all	  play	  a	  crucial	  role	  in	  pathogenesis	  and	  have	  been	  studied	  for	  their	  contribution	  to	  
P.	  aeruginosa	   infections	  for	  over	  40	  years	  (90).	  Although	  each	  of	  these	  toxins	  have	  unique	  targets	  and	  their	  activity	  against	  tissues	  varies	  from	  host	  to	  host,	  all	  three	  of	  these	  important	  virulence	  factors	  are	  regulated	  through	  the	  Las	  and	  Rhl	  QS	  systems	  in	  P.	  aeruginosa	  (102).	  The	  destructive	  impact	  of	  elastase	  has	  been	  well	  described	  in	  both	  acute	  and	  chronic	  lung	  infection	  models	  demonstrating	  that	  the	  elastases	  and	  proteases	  are	  effective	  weapons	  in	  the	  arsenal	  of	  P.	  aeruginosa	  (4,	  158).	  It	  is	  because	  of	   these	   studies	   that	   little	   surprise	   is	   drawn	   from	   the	   finding	   that	   elastases	   and	  proteases	  are	  expressed	  in	  the	  CF	  lung	  during	  chronic	  infections	  with	  P.	  aeruginosa	  (59,	  138).	  	  
1.1.4.2.5.	  Biofilms	  Over	   the	   past	   few	  decades,	   advances	   in	  methodologies	   and	   technologies	   in	  the	   field	   of	   bacteriology	   have	   lead	   to	   a	   change	   in	   the	   understanding	   of	   bacterial	  communities.	   The	   dogma	   of	   the	   day	   was	   that	   bacteria	   are	   single	   cell,	   free-­‐living	  organisms	  that	  rely	  little	  on	  the	  assistance	  of	  others	  to	  thrive.	  The	  ability	  to	  observe	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how	  bacteria	  live	  and	  grow	  and	  communicate	  in	  situ	  has	  provided	  new	  insights	  into	  the	   bacterial	   biofilm	  model	   showing	   instead	   that	   these	   unicellular	   organisms	   can,	  and	   often	   do,	   form	   highly	   organized	   and	   deliberately	   structured	   biological	  communities	   (19).	  P.	   aeruginosa	   is	   arguably	   the	  most	  well	   studied	   biofilm	   former	  and	  the	  phenotypic	  changes	  associated	  with	  biofilm	  growth	  have	  been	  recognized	  as	  a	  major	  contribution	  to	  the	  persistence	  of	  hospital	  acquired	  P.	  aeruginosa	  infections	  resulting	   from	   implantation	   devices	   including	   catheters	   and	   breathing	   tubes	   (19).	  The	  high	  level	  of	  intrinsic	  antibiotic	  resistance	  possessed	  by	  P.	  aeruginosa	  is	  further	  enhanced	   by	   numerous	   physiological	   changes	   that	   occur	   when	   the	   bacterium	  transitions	   into	   biofilm	   growth	   (33).	   Recently,	   developments	   in	  molecular	   biology	  techniques	   have	   enabled	   researchers	   to	   study	   the	   mechanisms	   by	   which	   many	  bacterial	   species	   are	   able	   to	   communicate	   and	   cooperate	   to	   form	  complex	  biofilm	  communities	   (18).	   Advances	   in	   our	   understanding	   of	   the	   regulatory	   networks	  responsible	   for	   triggering	   the	  switch	   from	  planktonic	   to	  biofilm	  growth	  have	  been	  rapid	  and	  studies	  have	  revealed	  that	  the	  quorum	  sensing	  networks	  of	  P.	  aeruginosa	  that	   are	   responsible	   for	   this	   transition	   are	   also	   tightly	   intertwined	   with	   the	  expression	   of	   many	   virulence	   factors,	   providing	   insights	   into	   the	   contribution	   of	  biofilms	  to	  pathogenicity	  in	  P.	  aeruginosa	  (24,	  25).	  It	  is	  now	  estimated	  that	  over	  half	  of	   all	   bacterial	   infections	   involve	   biofilms	   (111).	   	   It	   came	   as	   little	   surprise	   to	   CF	  researchers	  when	  Dr.	  Joseph	  Lam	  isolated	  mucoid	  microcolonies	  of	  P.	  aeruginosa	  in	  the	   sputum	   of	   chronically	   infected	   CF	   patients,	   a	   discovery	   that	  would	   ultimately	  lead	   to	   the	   conclusion	   that	   the	   chronic,	   impossible	   to	   eradicate,	   P.	   aeruginosa	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infections	   in	   the	  CF	   lung	  are	  caused	  by	  bacteria	  growing	  as	  biofilms	  with	   frequent	  exacerbations	   (67).	   Many	   advances	   have	   been	  made	   in	   our	   understanding	   of	   the	  contribution	  of	  biofilms	  to	  the	  pathogenicity	  of	  P.	  aeruginosa	  in	  the	  CF	  lung	  (3,	  154).	  This	  model	  of	  infection	  is	  now	  widely	  accepted	  and	  the	  bulk	  of	  the	  current	  research	  is	   directed	   at	   dispersing	   these	   biofilms	   by	   means	   of	   new	   antibiotics,	   combining	  antibiotic	   therapies	  with	   enzymes	   and	   iron	   chelators	   and	   by	   exposing	   biofilms	   to	  high	  doses	  of	  iron	  salts	  (89,	  91,	  135).	  	  
1.1.5.	  Current	  model	  systems	  
P.	  aeruginosa	   infection	  has	  been	  studied	   in	  an	  assortment	  of	  animal	  models	  ranging	  from	  insects	  and	  worms	  to	  fish	  and	  mammals	  in	  an	  attempt	  to	  tease	  apart	  the	  specific	  mechanisms	  of	  its	  unique	  virulence	  and	  resistance	  to	  host	  defense	  and	  antimicrobial	   therapies	   (66).	   These	   studies,	   however,	   have	   failed	   thus	   far	   to	  sufficiently	   explain	   the	   specific	   relationship	   between	   this	   opportunistic	   pathogen	  and	   mutations	   in	   the	   chloride	   channel	   CFTR.	   The	   favorite	   tools	   of	   researchers	  studying	   P.	   aeruginosa	   infections	   are	   mouse	   models,	   19	   of	   which	   have	   been	  established	   since	   1992,	   and	   cell	   culture	   techniques	   that	   utilize	   both	   primary	   and	  immortalized	   epithelial	   cell	   lines	   (66).	   	   Cell	   culture	   techniques	   have	   provided	   a	  wealth	   of	   information	   about	   how	   the	   loss	   of	   ion	   transport	   and	   membrane	  conductance	  affects	  the	  epithelial	  cells,	  but	  the	  scope	  of	  these	  experiments	  has	  been	  limited	   by	   the	   capacities	   of	   the	   in	   vitro	   model	   itself.	   Maintaining	   the	   epithelial	  differentiation	   in	   the	   immortalized	   CF	   bronchial	   epithelial	   lines	   has	   proven	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problematic	  and	  a	  number	  of	  factors	  related	  to	  culture	  technique	  have	  been	  shown	  to	  bias	  the	  results	  of	  many	  experiments.	  	  The	  wide	   array	   of	   available	  mouse	  models	   of	   CF	   can	   replicate	  many	  of	   the	  clinical	  symptoms	  of	  CF	  observed	  in	  humans.	  Inflammation,	  thick	  mucus	  secretions,	  poor	  nutrient	  uptake	  and	  reduced	  expression	  of	  Nitric	  Oxide	  Synthase	  have	  all	  been	  modeled	  in	  mice	  with	  mutated	  or	  knocked	  out	  CFTR.	  The	  most	  difficult	  symptom	  to	  replicate,	   though,	   are	   the	   respiratory	   tract	   infections	   seen	   in	   humans	   with	   CF,	  making	   most	   of	   the	   CFTR	   knockout	   mouse	   lines	   a	   very	   poor	   model	   to	   study	   the	  pathogenesis	  of	  P.	  aeruginosa	  during	   infections	  of	   the	   lung.	   Interestingly,	   the	  most	  promising	  model	  of	  the	  CF	  lung	  comes	  in	  the	  form	  of	  a	  mouse	  line	  with	  normal	  CFTR	  expression	   but	   an	   over	   expression	   of	   the	   epithelial	   sodium	   channel,	   closely	  mimicking	   the	   reduced	   salt	   secretion	   into	   and	   hydration	   of	   the	   airway	   surface	  liquid.	  This	  model,	  unfortunately,	   fails	   to	  recapitulate	   the	  majority	  of	  symptoms	  of	  CF	  and	  may	  not	  actually	  be	  sufficient	  to	  model	  the	  CF	  disease	  (66).	   	  Schroeder	  and	  colleagues	  have	  reported	  by	  far	  the	  most	  successful	  report	  of	  P.	  aeruginosa	  infection	  of	  a	  CF	  mouse	  model	  when	   they	  demonstrated	  reduced	  clearance	  of	  P.	  aeruginosa	  within	   5	   hours	   of	   inoculation	   using	   a	   CFTRΔF508	  mouse	   line	   (129).	   The	   authors	  claim	  that	  the	  mechanism	  for	  reduced	  clearance	  involves	  epithelial	  cell	  ingestion	  of	  the	  bacteria	  using	  CFTR	  as	  a	  membrane	  bound	  pattern	  recognition	  receptor.	  A	  great	  deal	  of	   controversy	  has	  been	   raised	  over	   the	  experimental	   techniques	  and	  overall	  conclusions	  of	  this	  work,	  but	  the	  reduced	  bacterial	  clearance	  may	  indeed	  make	  this	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study	  one	  of	   the	  most	   successful	   replications	  of	   the	  bacterial	   infections	  associated	  with	  CF	  using	  a	  murine	  model.	  	  
	  
1.2.	  Cystic	  fibrosis	  and	  the	  innate	  immune	  system	  	  
1.2.1.	  Overview	  The	  genetic	  basis	  for	  the	  disease	  cystic	  fibrosis	  is	  a	  defect	  in	  the	  chloride	  ion	  channel	  CFTR.	  This	  defective	  gene	  results	   in	  chronic	  persistent	  bacterial	   infections	  and	  a	  resultant	  hyperinflammation	  of	  the	  respiratory	  tract,	  a	  product	  of	  a	  failure	  of	  multiple	   facets	   of	   the	   immune	   response.	  Despite	   the	   resulting	   immunompromised	  condition	  associated	  with	  CF,	  CFTR	   is	  not	   traditionally	  considered	  a	  component	  of	  the	   immune	   response.	   The	   exact	   mechanisms	   of	   the	   susceptibility	   to	   bacterial	  infection	  in	  CF	  have	  been	  studied	  for	  decades	  and	  have	  provided	  insights	  into	  how	  this	  chloride	  channel	  may	  in	  fact	  contribute	  to	  an	  immune	  response	  (58).	  
1.2.2.	  Innate	  immune	  response	  to	  bacterial	  pathogens	  
1.2.2.1.	  Pattern	  recognition	  receptors	  	  
	   A	   primary	   line	   of	   defense	   against	   invading	   pathogens	   is	   activation	   of	   an	  innate	   immune	  response	  through	  pattern	  recognition	  receptors	  (PRRs)	  present	  on	  most	   cells.	   The	  Toll	   gene	   in	  drosophila	  was	  originally	   characterized	   for	   its	   role	   in	  dorso-­‐ventral	   patterning	   and	   was	   later	   implicated	   in	   defense	   against	   fungal	  infection	  in	  these	  insects	  (70).	  Since	  this	  discovery,	  the	  family	  of	  Toll-­‐Like	  Receptors	  (TLRs)	   has	   been	   expanded	   and	   well	   characterized.	   Upon	   recognition	   of	   their	  respective	  pathogen	  associated	  molecular	  patterns	  (PAMPS)	   that	  are	  distinctive	   to	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1.2.2.2.	  Cytokines	  	  	   The	  CF	  lung	  is	  characterized	  by	  a	  chronic	  hyperinflammation	  defined	  in	  part	  by	  an	  excess	  recruitment	  of	  neutrophils	  into	  the	  organ	  and	  the	  subsequent	  release	  of	   cytotoxic	   granules	   from	   these	   cells	   resulting	   in	   an	   endless	   feedback	   loop	   of	  inflammation	  that	  is	  ultimately	  unable	  to	  control	  the	  infections	  that	  prompted	  their	  initial	   recruitment	   (58,	   81).	   A	   debate	   has	   been	   raised	   among	   researchers	   as	   to	  whether	  this	  massive	  and	  importunate	  neutrophil	  response	  occurs	  independently	  of	  or	   as	   a	   result	   of	   bacterial	   infection.	   The	   accepted	   notion	   that	   the	   CF	   lung	   is	  physiologically	   normal	   at	   birth	   and	   begins	   to	   deteriorate	   in	   infancy	   has	   been	  challenged	   by	   a	   handful	   of	   clinical	   reports	   showing	   inflammation	   with	   no	  discernable	   infection,	   though	   these	   have	   largely	   been	   dismissed	   as	   evidence	   of	  subclinical	   infections	   in	   children	   makes	   diagnosis	   difficult	   (35,	   127).	   Efforts	   to	  explain	   the	   unrelenting	   neutrophil	   recruitment	   into	   the	   CF	   airway	   has	   led	  researchers	  to	  identify	  dramatic	  differences	  in	  the	  regulation	  of	  cytokine	  expression	  of	   CF	   epithelial	   cells	   compared	   to	   normal	   cells.	   	   Several	   studies	   have	   shown	   that	  airway	  epithelial	  cells	  of	  both	  primary	  and	   immortalized	   lines	  express	  abnormally	  high	   levels	   of	   the	   pro-­‐inflammatory	   cytokines	   IL-­‐8,	   IL-­‐6,	   IL-­‐1β	   and	  TNFα,	   coupled	  with	  a	  decrease	   in	   the	  expression	  of	   the	  anti-­‐inflammatory	  cytokine	   IL-­‐10	  (5,	  120,	  140).	   Several	   hypotheses	   exist	   to	   describe	   the	   excessive	   production	   of	   pro-­‐inflammatory	  cytokines	  by	  the	  CF	  cells,	  among	  the	  more	  widely	  accepted	  is	  that	  the	  most	  common	  mutation	  in	  CF	  results	  in	  an	  improper	  folding	  of	  the	  protein	  resulting	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in	  sequestration	  at	  the	  golgi	  for	  destruction	  (124).	  This	  process	  is	  thought	  to	  explain	  the	  increased	  cell	  stress	  that	  occurs	  that	  may	  ultimately	  result	  in	  inflammation.	  
1.2.2.3.	  Phagocyte	  response	  	   The	  commonly	  accepted	  dogma	  of	  hyperinflammation	   in	   the	  CF	  airway	  has	  led	   many	   researchers	   and	   clinicians	   to	   accept	   the	   idea	   of	   rapid	   neutrophil	  infiltration	  into	  the	  lung	  in	  response	  to	  bacterial	  pathogens	  that	  they	  will	  ultimately	  struggle	   to	  eradicate.	  These	  notions	  have	  been	  called	   into	  question	  by	  researchers	  who	  have	  found	  that	  isolated	  neutrophils	  from	  CF	  patients	  display	  altered	  patterns	  of	  directed	  chemotaxis	  compared	   to	  neutrophils	   from	  healthy	   individuals	  and	   that	  these	  alterations	  may	  correlate	  with	  the	  clinical	  condition	  of	  the	  patients	  (131).	  This	  report	   trails	   a	   study	   that	   indicated	   that	   CF	   neutrophils	   display	   a	   significant	  desensitization	  to	  pro-­‐inflammatory	  cytokines	  based	  largely	  on	  their	  over-­‐exposure	  to	  these	  cytokines	  in	  CF	  patients	  (17).	  	  
	  Figure	   1.3.	   Model	   of	   the	   Chlorination	   Defect	   in	   the	   Lysozome	   of	   CF	  Macrophages.	   Adapted	   from	   Di,	   et	   al.	   2006.	   CFTR	   regulates	  phagosome	   acidification	   in	   macrophages	   and	   alters	   bactericidal	  activity.	  Nature	  Cell	  Biology	  8(9):933-­‐944	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   Recently,	   a	   novel	   function	   for	   CFTR	   has	   been	   described	   in	   macrophages,	  neutrophils	   and	  eosinophils	   (30,	   99,	   130).	   CFTR	  expression	  has	  been	   identified	   at	  very	   low	  levels	   in	  macrophages,	  neutrophils	  and	  eosinophils	   isolated	  from	  healthy	  individuals	   and	   the	   intracellular	   localization	   of	   the	   protein	   is	   confined	   to	   the	  membrane	  of	  the	  phagolysosome	  of	  these	  cells.	  The	  function	  of	  the	  ion	  channel	  here	  is	   multifaceted	   and	   its	   contributions	   are	   thought	   to	   include	   supplying	   Cl-­‐	   for	   the	  production	   of	   HOCl,	   a	  major	   player	   in	   bacterial	   killing,	   the	   establishment	   of	   a	   H+	  gradient	  across	   the	  membrane,	   facilitating	   the	  activity	  of	   the	  NADPH	  Oxidase,	   and	  finally	   lowering	   the	   pH	   of	   the	   lysosomal	   compartment	   to	   aid	   in	   elimination	   of	  phagocytosed	   pathogens	   and	   debris.	   These	   recently	   identified	   functions	   of	   CFTR	  represent	   a	   defined	   mechanism	   to	   explain	   how	   loss	   of	   this	   ion	   channel	   can	  significantly	  alter	   immune	  response	  by	  reducing	  the	  ability	  of	   innate	   immune	  cells	  to	  produce	  reactive	  oxygen	  species	  to	  eradicate	  invading	  pathogens.	  
	  
1.3.	  Zebrafish	  as	  a	  model	  organism	  	  
1.3.1.	  Overview	  
	   The	   zebrafish	   has	   received	   a	   great	   deal	   of	   attention	   as	   an	   ideal	  model	   for	  studying	   embryonic	   development	   and	  many	   human	   diseases.	   In	   fact,	  many	   of	   the	  advantages	  that	  make	  the	  zebrafish	   ideal	   for	  studying	  development	  also	  make	  this	  model	  well	  suited	   for	  studying	   infectious	  disease	  (74).	  The	  relatively	   low	  cost	  and	  ease	   of	   maintenance	   make	   the	   zebrafish	   a	   cheaper	   and	   easier	   alternative	   to	   the	  more	  popular	  mouse	  models.	  The	  optically	  clear	  embryos	  spawned	  by	  the	  zebrafish,	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coupled	  with	  development	  external	  to	  the	  mother	  make	  the	  zebrafish	  an	  ideal	  model	  for	  studying	  embryonic	  development	  and	  also	  offer	  many	  advantages	   for	   infection	  studies	  (84).	  Because	   the	  embryos	  are	  optically	   transparent,	   they	  are	  amenable	   to	  microscopic	  observations	  of	  the	  infection	  processes	  in	  a	  live	  animal,	  something	  that	  is	  very	  difficult	  to	  do	  with	  mice.	  Much	  progress	  has	  been	  made	  in	  understanding	  the	  cellular	   mechanisms	   by	   which	   the	   zebrafish	   defends	   itself	   from	   pathogens.	   An	  ongoing	  effort	   to	  describe	  the	  hematopoietic	  origins	  of	  zebrafish	   immune	  cells	  has	  lead	  to	  the	  discovery	  that	  those	  origins	  are	  very	  similar	  to	  mammalian	  lymphocytes	  (20).	   With	   the	   continuing	   effort	   to	   fully	   sequence	   the	   genome	   and	   the	   push	   to	  characterize	  the	  predicted	  genes	  found	  through	  this	  process,	  much	  has	  been	  learned	  about	   the	   zebrafish	   and	   the	   functional	   similarities	   many	   of	   its	   genes	   share	   with	  humans.	   The	   ongoing	   development	   of	   genetic	   tools	   for	   the	   zebrafish	   has	   yielded	  many	  new	  ways	  to	  study	  inflammatory	  processes	  and	  host–pathogen	  responses	  in	  a	  way	   that	   could	   not	   be	   replicated	   in	   vitro	   and	   simply	   could	   not	   be	   performed	   in	  murine	  models	  (61).	  
1.3.2.	  Zebrafish	  innate	  immunity	  
1.3.2.1.	  TLRs	  and	  Cytokines	  	   It	  has	  been	  shown	  that	  the	  innate	   immune	  system	  is	  well	  conserved	  among	  all	  animals,	  from	  insects	  to	  vertebrates,	  and	  is	  a	  crucial	  first	  line	  of	  defense	  against	  invading	  microorganisms.	   This	   conservation	   of	   both	   structure	   and	   function	   holds	  true	   when	   comparing	   the	   zebrafish	   and	   human	   innate	   immune	   system	   (146).	  Pathogen	   recognition	   and	   subsequent	   immune	   response,	   including	   the	   release	   of	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pro-­‐inflammatory	   cytokines	   and	   interferon,	   through	   TLRs	   occurs	   in	   a	   similar	  manner	   in	   zebrafish	   and	   humans	   and	   although	   some	   of	   the	   intermediates	   are	  different,	   the	  end	  result	   is	  very	  much	  the	  same.	  Twenty-­‐four	  TLR	  genes	  have	  been	  identified	   in	  zebrafish,	  many	  more	   than	   in	  mammals,	  and	  characterization	  of	   their	  expression	   and	   function	   has	   been	   ongoing.	   The	   conservation	   of	   downstream	  expression	  of	  pro-­‐inflammatory	  cytokines	  between	  zebrafish	  and	  human	  has	  been	  well	   documented	   (146).	   Numerous	   studies	   in	   the	   zebrafish	   have	   demonstrated	  cytokine	   responses	   to	   bacterial	   pathogens.	   In	   2005,	   Pressley	   and	   colleagues	  demonstrated	   that	   TNFα	   and	   IL-­‐1β	  were	   found	   to	   be	   up-­‐regulated	   upon	   infection	  with	  the	  natural	  fish	  pathogen	  Edwardsiella	  tarda	  (113).	  Researchers	  have	  begun	  to	  explore	  the	  specific	  functions	  of	  some	  of	  these	  pro-­‐inflammatory	  cytokines,	  such	  as	  the	   neutrophil	   recruiting	   Interleukin	   8,	   to	   compare	   them	   to	   the	  more	   thoroughly	  described	  mammalian	  orthologs	  (97).	  
1.3.2.2.	  Zebrafish	  phagocytes	  	  Many	   aspects	   of	   the	   cell-­‐mediated	   branch	   of	   the	   innate	   immune	   system	   of	  zebrafish	  have	  been	  elucidated	  through	  studies	  challenging	  the	  fish	  with	  many	  viral	  and	   bacterial	   pathogens.	   The	   lineage	   of	   zebrafish	   neutrophils	   has	   recently	   been	  traced	  back	   to	   the	   same	  myeloid	   lineage	   as	   zebrafish	  macrophages	   (69).	   Through	  histological	   staining	   techniques	   and	   fluorescently	   labeled	   antibodies,	   Le	   Guyader	  and	   collages	   were	   able	   to	   show	   that	   neutrophils	   of	   zebrafish	   behave	   much	  differently than mammalian neutrophils. Unlike in mammals, where macrophages are 
often found in tissue and neutrophils are more frequently found circulating in blood,  
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zebrafish neutrophils typically reside in the tissues and exhibit rapid chemotaxis to 
wound or infection sites	  (69).	  They	  were	  also	  able	  to	  show	  that	  although	  migration	  to	  infection	   with	   E.	   coli,	   zebrafish	   neutrophils	   were	   rarely	   found	   to	   engulf	   these	  bacteria,	   leading	   them	   to	   speculate	   that	   the	   neutrophils	   and	   macrophages	   of	  zebrafish	   respond	   differently	   depending	   on	   the	   pathogen.	   Since	   this	   study,	   many	  reports	   have	   been	   published	   showing	   the	   varying	   degree	   of	   participation	  neutrophils	  play	  in	  combating	  infections	  with	  different	  pathogens	  (7,	  69,	  112,	  152).	  The	   introduction	  of	   the	  Tg(mpx:GFP)	   transgenic	   line	  of	  zebrafish	   in	  which	  a	  green	  fluorescent	   protein	   is	   expressed	   under	   the	   neutrophil	   specific	   myeloperoxidase	  (MPX)	   promoter	   has	   provided	   new	   insights	   into	   how	   neutrophils	   migrate	   to	   and	  combat	  different	  pathogens	   in	   a	   live	   animal	  model	   (123).	  This	   transgenic	   line	  has	  been	   utilized	   in	   studies	   attempting	   to	   elucidate	   neutrophil	   locomotion	   and	   how	  these	  cells	  are	  recruited	  to	  sites	  of	  infection	  and	  tissue	  injury	  (122).	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  Figure	   1.4.	   Production	   of	   Reactive	   Oxygen	   Species	   Following	   the	  Respiratory	   Burst.	   Adapted	   from	   Hampton,	   et	   al.	   1998.	   Inside	   the	  Neutrophil	   Phagosome:	   Oxidants,	   Myeloperoxidase,	   and	   Bacterial	  Killing.	  Blood	  92(9):3007-­‐3017	  	  A	   crucial	   contribution	   of	  macrophages	   and	   neutrophils	   during	   the	   immune	  response	   to	   pathogens	   is	   the	   respiratory	   burst	   response	   and	   the	   resulting	  production	  of	  reactive	  oxygen	  species	  (ROS)	  (Figure	  1.4).	  Many	  assays	  are	  available	  to	  measure	   the	   production	   of	   reactive	   oxygen	   species	   in	   isolated	   neutrophils	   and	  methods	   have	   been	   reported	   for	   neutrophils	   of	   both	   fish	   and	  mammals	   (8,	   50).A	  novel	   technique	   for	  performing	  whole	  embryo	  measurements	  of	   respiratory	  burst	  has	   been	   reported	   in	  which	   exposure	   of	   zebrafish	   embryos	   to	   toxicants	   has	   been	  shown	  to	  hamper	  the	  ability	  of	  zebrafish	  neutrophils	  to	  produce	  ROS	  (53,	  92).	  This	  assay	  was	  adapted	  from	  one	  reported	  to	  detect	  immune	  affects	  of	  toxicant	  exposure	  in	  neutrophils	  extracted	  from	  rainbow	  trout	  (8).In	  the	  whole	  embryo	  assay,fish	  are	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exposed	   to	   the	  non-­‐fluorescent,	   reduced	  2',7'-­‐dichlorodihydrofluorescein	  diacetate	  	  and	  phorbol	  12-­‐myristate	  13-­‐acetate	  (PMA)	  is	  used	  to	  activate	  protein	  kinase	  C	  and	  synthetically	   induce	   a	   respiratory	   burst	   response.	   The	   ROS	   produced	   during	   this	  burst	   are	   then	   quantified	   by	   measuring	   the	   fluorescence	   produced	   by	   the	   de-­‐acetylated	  dichlorodihydrofluorescein. The	  availability	  of	  this	  assay	   is	  a	  significant	  advantage	  of	   the	   zebrafish	  model	   as	   it	   is	   a	   relatively	   inexpensive,	   technically	   easy	  and	  quantitatively	   precise	  method	  of	  measuring	   the	   overall	   immune	  health	   of	   the	  animal	   after	   exposure	   to	   a	   toxicant	   or	   genetic	   manipulation.	   The	   assay	   is	  particularly	  useful	  in	  studies	  involving	  host	  –	  pathogen	  interactions	  in	  CF	  because	  of	  the	  critical	  role	  neutrophils	  play	  in	  combating	  infections	  in	  the	  CF	  lung.	  	  
1.3.3.	  Zebrafish	  and	  infectious	  disease	  	  
1.3.3.1.	  Bacterial	  infection	  models	  	   Recently,	   the	   zebrafish	   has	   gained	   popularity	   among	   researchers	   as	   a	  powerful	  tool	  for	  elucidating	  host–pathogen	  interactions	  in	  vivo.	  In	  the	  past	  10	  years	  alone,	  the	  number	  of	  bacterial	  pathogens	  that	  have	  been	  described	  in	  zebrafish	  has	  risen	  from	  only	  a	  handful	  to	  nearly	  30	  different	  organisms	  (listed	  in	  Table	  1.2.)	  (61).	  This	  rise	  in	  popularity	  as	  a	  model	  host	  has	  come	  on	  the	  heels	  of	  studies	  describing	  the	   structural	   and	   functional	  homology	  of	   the	  zebrafish	   immune	  system	   to	   that	  of	  mammals	  (20,	  122).	   	  Recently,	   two	  separate	  groups	  of	  researchers	  have	  described	  the	  pathogenesis	  of	  P.	  aeruginosa	  in	  the	  zebrafish	  (7,	  12).	  Both	  groups	  described	  the	  importance	   of	   the	   phagocytes	   of	   the	   zebrafish	   embryo	   in	   the	   clearance	   of	   a	   P.	  
aeruginosa	   infection	   and	   showed	   that	   several	   virulence	   factors	   of	   P.	   aeruginosa	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SPECIFIC	  RESISTANCE	  TO	  PSEUDOMONAS	  AERUGINOSA	  INFECTION	  IN	  
ZEBRAFISH	  IS	  MEDIATED	  BY	  THE	  CYSTIC	  FIBROSIS	  TRANSMEMBRANE	  
CONDUCTANCE	  REGULATOR	  
	  
2.1.	  Abstract	  Cystic	  fibrosis	  (CF)	  is	  a	  genetic	  disease	  caused	  by	  recessive	  mutations	  in	  the	  Cystic	   Fibrosis	   Transmembrane	   Conductance	   Regulator	   (CFTR)	   gene	   and	   is	  associated	   with	   prevalent	   and	   chronic	   Pseudomonas	   aeruginosa	   lung	   infections.	  Despite	   numerous	   studies	   that	   have	   sought	   to	   elucidate	   the	   role	   of	   CFTR	   in	   the	  innate	   immune	   response,	   the	   links	   between	   CFTR,	   innate	   immunity,	   and	   P.	  
aeruginosa	  infection	  remain	  unclear.	  The	  present	  work	  highlights	  the	  zebrafish	  as	  a	  powerful	  model	  organism	  for	  human	  infectious	  disease,	  particularly	  infection	  by	  P.	  
aeruginosa.	   	   Zebrafish	   embryos	   with	   reduced	   expression	   of	   the	   cftr	   gene	   (Cftr	  morphants)	  exhibited	   reduced	  respiratory	  burst	   response	  and	  directed	  neutrophil	  migration,	  supporting	  a	  connection	  between	  cftr	  and	  the	   innate	   immune	  response.	  	  Cftr	  morphants	  were	  infected	  with	  P.	  aeruginosa	  or	  other	  bacterial	  species	  that	  are	  commonly	   associated	   with	   infections	   in	   CF	   patients,	   including	   Burkholderia	  
cenocepacia,	   Haemophilus	   influenzae,	   and	   Staphylococcus	   aureus.	   Intriguingly,	   the	  bacterial	  burden	  of	  P.	  aeruginosa	  was	   found	   to	  be	  significantly	  higher	   in	  zebrafish	  Cftr	  morphants	   than	   in	   controls,	   but	   this	  phenomenon	  was	  not	  observed	  with	   the	  other	   bacterial	   species.	   	   Bacterial	   burden	   in	   Cftr	   morphants	   infected	   with	   a	   P.	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aeruginosa	   ΔLasR	   mutant,	   a	   quorum	   sensing-­‐deficient	   strain,	   was	   comparable	   to	  that	  in	  control	  fish	  indicating	  that	  the	  regulation	  of	  virulence	  factors	  through	  LasR	  is	  required	  for	  enhancement	  of	   infection	  in	  the	  absence	  of	  Cftr.	  The	  zebrafish	  system	  provides	  a	  multitude	  of	  advantages	   for	   studying	   the	  pathogenesis	  of	  P.	  aeruginosa	  and	  for	  understanding	  the	  role	  that	  innate	  immune	  cells	  such	  as	  neutrophils	  play	  in	  the	   host	   response	   to	   acute	   bacterial	   infections	   commonly	   associated	   with	   cystic	  fibrosis.	  	  
2.2.	  Introduction	  Cystic	  fibrosis	  (CF)	  is	  a	  multi-­‐organ	  genetic	  disorder	  characterized	  by	  chronic	  pulmonary	  infections	  as	  well	  as	  gastrointestinal	  and	  reproductive	  abnormalities.	  In	  1989	   it	   was	   discovered	   that	   CF	   results	   from	   mutations	   in	   the	   Cystic	   Fibrosis	  Transmembrane	   Conductance	   Regulator	   (CFTR)	   gene	   (63),	   which	   encodes	   a	  chloride	  ion	  channel	  present	  in	  most	  epithelial	  cells.	  Today,	  80–95%	  of	  CF	  patients	  succumb	  to	  respiratory	   failure	  resulting	   from	  chronic	   lung	   infections	   that	  begin	   in	  early	   childhood	   and	   that	   are	   caused	   primarily	   by	  P.	   aeruginosa	   (16,	   80).	   	   Chronic	  infection	  with	  the	  bacterium	  leads	  to	  hyperinflammation	  characterized	  by	  excessive	  recruitment	  of	  neutrophils	   to	   the	  airways,	  and	  subsequent	  release	  of	  oxidants	  and	  enzymes	  from	  activated	  neutrophils,	  which	  damages	  the	  lung	  tissue	  over	  time	  (80).	  	  
Pseudomonas	   aeruginosa	   is	   a	   flagellated	   Gram-­‐negative	   opportunistic	  pathogen	   of	   plants	   and	   animals	   and	   is	   found	   naturally	   in	   soil	   and	   water.	   	   As	   a	  nosocomial	   pathogen,	   it	   is	   the	   third	  most	   commonly	   isolated	   organism,	   primarily	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leading	  to	  urinary	  tract	  or	  wound	  infections	  in	  immunocompromised	  patients	  (47).	  	  Due	   to	   its	  production	  of	  alginate,	   the	   low	  permeability	  of	   its	  outer	  membrane	  and	  the	   presence	   of	   multidrug	   efflux	   pumps,	   P.	   aeruginosa	   exhibits	   a	   high	   degree	   of	  intrinsic	  antibiotic	   resistance	   (125),	  making	   infections	  by	   this	  bacterium	  a	   serious	  concern	   to	   hospital-­‐bound	   patients.	   Myriad	   virulence	   factors	   carried	   by	   this	  bacterium	  afford	  P.	  aeruginosa	  the	  ability	  to	  infect	  a	  broad	  range	  of	  species	  (12).	  The	  Type	  III	  Secretion	  System	  enables	  the	  direct	  transfer	  of	  exotoxins	  from	  P.	  aeruginosa	  into	   the	   cytoplasm	  of	   eukaryotic	   cells	   and	  has	   been	   shown	   to	   be	   required	   for	   full	  virulence	  in	  zebrafish	  (7,	  12)	  and	  directly	  linked	  to	  tissue	  destruction	  and	  infection	  of	  the	  mouse	  lung	  (40).	  LasR,	  a	  transcriptional	  regulator	  of	  quorum	  sensing,	  controls	  the	   expression	   of	   numerous	   virulence	   factors,	   including	   elastases,	   proteases,	  pyocyanin	  and	  hydrogen	  cyanide,	  and	  facilitates	  the	  transition	   into	  biofilm	  growth	  in	  P.	  aeruginosa	  (12,	  31).	  Among	  the	  most	  puzzling	  questions	  in	  cystic	  fibrosis	  research	  is	  why	  patients	  are	  susceptible	  to	  P.	  aeruginosa	  infection	  in	  particular.	  In	  non-­‐CF	  patients,	  the	  most	  common	  respiratory	  bacterial	  pathogen	  is	  Streptococcus	  pneumoniae	  (114)	  while	  P.	  
aeruginosa	   is	   rarely	   isolated	   (79).	   Studies	   that	   identified	   CFTR	   as	   a	   pattern	  recognition	   receptor	   for	   P.	   aeruginosa	   have	   linked	   CFTR	   deficiency	   to	   reduced	  bacterial	  clearance	  early	   in	  the	  course	  of	   infection	   in	  CFTR	  knockout	  mice	  (38,	  48,	  65,	  129).	  	  Recently,	   the	   zebrafish	   has	   become	   recognized	   as	   a	   useful	   model	   for	   the	  study	  of	   infectious	  disease	  (22,	  52,	  75,	  84-­‐86,	  94,	  95,	  103,	  113,	  123,	  149,	  160)	  and	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the	  pathogenesis	  of	  P.	  aeruginosa	  has	  been	  described	  (7,	  12).	  Zebrafish	  embryos	  are	  particularly	  amenable	  to	  microscopic	  visualization,	  as	  they	  are	  optically	  clear,	  thus	  allowing	   real-­‐time	   analysis	   of	   a	   bacterial	   infection.	   By	   far	   the	   most	   important	  advantage	  is	  the	  fact	  that	  for	  the	  first	  30	  days	  post	  fertilization	  zebrafish	  rely	  solely	  on	   the	   innate	   immune	   system	   for	   host	   defense	   against	   pathogens	   (20).	   After	  approximately	   4	   weeks	   zebrafish	   gain	   a	   functional	   adaptive	   immune	   system,	   at	  which	   time	   the	   interaction	   between	   innate	   and	   adaptive	   immunity	   may	   be	  examined.	  Invertebrates	  such	  as	  C.	  elegans	  and	  Drosophila	  have	  no	  adaptive	  immune	  system	  but	  possess	  only	  a	  very	  simple	  innate	  immune	  system	  and	  one	  primitive	  cell	  type,	   the	   hemocyte,	   which	   is	   thought	   to	   carry	   out	   some	   of	   the	   functions	   of	   both	  macrophages	   and	   neutrophils	   in	   evolutionarily	   higher	   species	   (78).	   The	   use	   of	  morpholino	   antisense	   oligonucleotide	   (MO)	   technology	   in	   zebrafish	   embryos	   has	  facilitated	  the	   functional	  characterization	  of	  many	  zebrafish	  genes,	   including	  those	  involved	  in	  innate	  immunity	  (2,	  7,	  150).	  	  	  In	  the	  present	  study,	  the	  role	  of	  Cftr	  in	  the	  zebrafish	  innate	  immune	  response	  to	  acute	  infection	  with	  P.	  aeruginosa	  was	  evaluated	  through	  targeted	  knockdown	  of	  Cftr.	   	   Knockdown	   of	   Cftr	   perturbs	   multiple	   innate	   immune	   responses	   in	   the	  zebrafish	   embryo.	   Dampened	   respiratory	   burst	   response	   and	   reduced	   neutrophil	  migration	  both	  indicate	  that	  cftr	  plays	  a	  vital	  role	  in	  the	  host	  response	  to	  infection.	  Of	   greatest	   interest	   was	   the	   finding	   that	   P.	   aeruginosa	   bacterial	   burden	   was	  significantly	   higher	   in	   Cftr	   morphants	   than	   control	   embryos	   at	   8	   hours	   post	  infection	   (hpi),	   which	   parallels	   similar	   studies	   performed	   in	   mice	   and	   human	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bronchial	   epithelial	   cells.	   	   The	   reduced	   ability	   to	   clear	   the	   infection	  was	  observed	  only	   when	   morphants	   were	   challenged	   with	   P.	   aeruginosa	   and	   not	   with	   other	  bacterial	  pathogens,	   including	   those	  commonly	   isolated	   from	  CF	  sputum.	   Infection	  with	  a	  P.	  aeruginosa	  mutant	  defective	  in	  the	  LasR	  transcriptional	  regulator	  did	  not	  result	  in	  an	  increase	  in	  bacterial	  burden	  in	  the	  morphants	  compared	  to	  the	  controls.	  The	  zebrafish	  embryo	  is	  a	  promising	  new	  model	  for	  the	  study	  of	  the	  host	  response	  to	   acute	   infections	  by	  P.	   aeruginosa	   and	   the	   effect	   of	   cftr	   on	   innate	   immunity	   and	  bacterial	  clearance.	  	  
2.3.	  Materials	  and	  Methods	  
2.3.1.	  Zebrafish	  care	  and	  maintenance.	  	  	  Zebrafish	   were	   housed	   at	   the	   University	   of	   Maine	   Zebrafish	   Facility	   in	  recirculating	   systems	   (Aquatic	   Habitats,	   Apopka,	   FL).	   	   Water	   temperature	   was	  maintained	   at	   28°C	   with	   a	   total	   system	   flow	   rate	   of	   150	   L/min.	   	   Zebrafish	   were	  maintained	   in	   accordance	   with	   the	   Institutional	   Animal	   Care	   and	   Use	   Committee	  standards.	  	  Adult	  zebrafish	  (>3	  months	  old)	  were	  used	  for	  breeding	  embryos	  which	  were	   reared	   in	   Petri	   dishes	   containing	   60	  mL	   of	   embryo	   rearing	  medium	   (ERM)	  (0.137	  M	  NaCl,	  5.4	  mM	  KCl,	  0.25	  mM	  Na2HPO4,	  0.44	  mM	  KH2PO4,	  1.3	  mM	  CaCl2,	  1.0	  mM	  MgSO4,	  4.2	  mM	  NaHCO3).	   	  Strains	  used	  were	  Wild	  Type	  AB	  and	  the	  transgenic	  AB	   strain	   Tg(mpx:GFP)i114	   expressing	   enhanced	   green	   fluorescent	   protein	   (EGFP)	  driven	  by	  the	  neutrophil	  specific	  myeloperoxidase	  promoter	  (123),	  kindly	  provided	  by	  Dr.	  Stephen	  Renshaw	  (University	  of	  Sheffield,	  Sheffield,	  UK).	  Until	  24	  hours	  post	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fertilization	   (hpf),	   ERM	   was	   supplemented	   with	   0.3	   mg	   of	   methylene	   blue/L	   to	  prevent	  fungal	  growth.	  	  ERM	  was	  changed	  daily.	  





2.3.3.	  Bacterial	  strains	  and	  growth	  conditions.	  Wild-­‐type	   non-­‐mucoid	   P.	   aeruginosa	   strain	   PA14,	   PA14	   ΔLasR	   and	   PA14	  ΔT3SS	  were	  generously	  provided	  by	  Dr.	  George	  A.	  O’Toole	  and	  Dr.	  Deborah	  A.	  Hogan	  (Dartmouth	  Medical	   School,	   Hanover,	   NH).	   	   Strain	   PA14(p67T1)	   was	   constructed	  recently	  (134)	  and	  carries	  a	  constitutive	  plasmid-­‐encoded	  RFP	  variant	  of	  d-­‐Tomato	  that	  was	  engineered	  by	  Shaner	  et	  al.	  (132).	  P.	  aeruginosaCF	  lung	  isolate,	  designated	  SMC573	   was	   provided	   by	   Dr.	   Joe	   Schwartzman	   (Dartmouth-­‐Hitchcock	   Medical	  Center,	  Lebanon,	  NH).	  	  P.	  aeruginosastrains	  were	  grown	  on	  cetrimide	  selective	  agar	  (Accumedia,	  Lansing	  MI).	  PA14(p67T1)cultures	  were	  supplemented	  with	  750	  µg	  of	  ampicillin/ml.	   	   Edwardsiella	   tarda	   was	   grown	   on	   Edwardsiella	   ictaluri	   medium	  (EIM)	  (133).	  Burkholderia	  cenocepacia	  clinical	  isolate	  strain	  J2315	  was	  cultured	  on	  
Burkholderia	   cepacia	   selective	   agar	   (BCSA)	   (51).	  Staphylococcus	   aureus	   laboratory	  strain	   MZ100	   (provided	   by	   George	   O’Toole)	   was	   grown	   on	   tryptic	   soy	   agar	  supplemented	   with	   5%	   sheep	   blood	   (Northeast	   Laboratories,	   Waterville,	   ME).	  
Haemophilus	   influenza	   type	   b	   strain	   EAGAN,	   a	   gift	   from	   Dr.	   Brian	   Ackerley	  (University	   of	   Massachusetts	   Medical	   School,	   Worcester,	   MA),	   was	   grown	   on	  chocolate	   agar	   supplemented	   with	   16,000	   units	   of	   bacitracin	   per	   liter	   (BD	  Bioscience,	  Sparks,	  MD).	  E.	  coli	  XL-­‐10	  (Stratagene,	  Cedar	  Creek,	  TX)	  was	  grown	  on	  sorbitol	   Mackonkey	   Agar	   (BD	   Bioscience,	   Sparks,	   MD).	   Prior	   to	   infection	  experiments,	  liquid	  cultures	  were	  grown	  for	  12	  h	  at	  37°C	  with	  shaking	  (250	  rpm)	  in	  L-­‐broth(USB,	  Cleveland,	  OH),	  except	  H.	   influenzae,	  which	  was	  grown	  in	  brain	  heart	  infusion	  broth	  supplemented	  with	  10	  mg	  of	  Hematin	  (Sigma-­‐Aldrich)	  and	  10	  mg	  of	  
	  	  
	  37	  
NAD	  per	  liter	  (MP	  Biomedical,	  Solon,	  OH),	  harvested	  by	  centrifugation	  and	  washed	  twice	  in	  Dulbecco’s	  phosphate	  buffered	  saline	  (dPBS).	  Cell	  density	  was	  determined	  spectrophotometrically	  and	  adjusted	  to	  107	  CFU/ml	  in	  dPBS.	  
2.3.4.	  Morpholino	  knockdown.	  Morpholino	   antisense	   oligonucleotides	   (MOs)	   against	   zebrafish	   Cftr	  (GenBank	   accession	   no.	   NM_001044883)	   were	   synthesized	   by	   Gene	   Tools	  (Philomath,	  OR),	   reconstituted,	   and	   stored	   in	  Danieau’s	  buffer.	  CFTR	   I1E2	  MO	  (5’-­‐CCACCTGTAAATATTCAGAGCAGAT-­‐3’)	  anneals	   to	   the	   intron	  1/exon	  2	  boundary	  of	  the	   transcript	   and	   results	   in	   the	   deletion	   of	   exon	   2.	   	   CFTR	   Trans	   MO	   (5’-­‐CATCCTCCACAGGTGATCTCTGCAT-­‐3’)	   anneals	   to	   the	   AUG	   start	   site	   and	   blocks	  translation.	   	  Unless	  otherwise	  noted,	  Cftr	  knockdown	  was	  achieved	  by	  co-­‐injecting	  1.25	   ng	   of	   each	   CFTR	  MO	   per	   embryo.	   Two	   and	   one	   half	   nanograms	   of	   Standard	  Control	  Morpholino	  (Gene	  Tools,	  Philomath,	  OR)	  was	   injected	  per	  control	  embryo.	  	  Prior	   to	   injection,	   MO	   solutions	   were	   supplemented	   with	   0.01%	   phenol	   red	   to	  permit	   visualization.	   	   Zebrafish	   embryos	   at	   the	  1–2	   cell	   stage	  were	  disinfected	  by	  rinsing	   with	   Perosan	   (Zep	   Manufacturing,	   Atlanta,	   GA)	   for	   1	   minute,	   then	  microinjected	   with	   5	   nL	   of	   MO	   solution	   in	   the	   yolk,	   using	   an	   MPPI-­‐2	   pressure	  injection	   system	   (Applied	   Scientific	   Instrumentation,	   Eugene,	   OR).	   To	   determine	  whether	   co-­‐injection	   of	   both	   CFTR	   morpholinos	   would	   yield	   the	   same	   effect	   on	  bacterial	   burden	   as	   would	   each	   injected	   separately,	   embryos	   were	   injected	   with	  either	  CFTR	  MO	  or	  both	  MOs	  simultaneously,	  and	  subsequently	  infected.	  	  Each	  CFTR	  MO	  was	  capable	  of	  exerting	  an	  independent	  effect	  on	  the	  bacterial	  burden	  (data	  not	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shown).	   	  However,	   the	   two	  MOs	   injected	   together	   appeared	   to	   exert	   a	   synergistic	  effect,	  despite	  the	  fact	  that	  the	  dose	  of	  total	  MO	  (2.5	  ng	  per	  fish)	  remained	  constant	  in	   all	   groups.	   	   For	   rescue	   experiments,	   wild	   type	   zebrafish	   cftr	   was	   cloned	   into	  pCS2+(148),	   linearized,	   transcribed	   into	   capped	  RNA	  by	  SP6	  mMessage	  mMachine	  (Ambion)	  and	  purified	  by	  LiCl	  precipitation.	  Approximately	  100	  pg	  of	  cftr	  RNA	  in	  1x	  Danieau	  buffer	  containing	  0.01%	  phenol	  red	  was	  simultaneously	  injected	  at	  the	  1–2	  cell	  stage	  with	  the	  2.5	  ng	  of	  I1E2	  MO.	  
2.3.5.	  Infection	  by	  microinjection.	  Zebrafish	  embryos	  (48	  hpf)	  were	  manually	  dechorionated	  and	  anesthetized	  by	   immersion	   in	   Tris-­‐buffered	   tricaine	  methane	   sulfonate	   (200	   µg/mL)	   (Western	  Chemicals,	   Inc.,	   Ferndale,	   WA).	   	   Unless	   otherwise	   noted,	   approximately	   5	   nl	   of	  bacterial	   suspension	   was	   microinjected	   into	   the	   duct	   of	   Cuvier	   as	   described	   by	  Clatworthy	  et	  al.	  (12)	  using	  the	  injection	  system	  described	  above.	  Inocula	  of	  50	  CFU	  per	  fish	  were	  injected	  into	  embryos	  for	  infection	  experiments	  with	  P.	  aeruginosa,	  E.	  
coli,	   E.	   tarda,	   B.	   cenocepacia,	   S.	   aureus	  and	  H.	   influenzae.	   Statistical	   significance	   of	  mortality	  was	  determined	  by	  Log-­‐Rank	  Test	  and	  by	  the	  Wilcoxon	  Test.	  
2.3.6.	  Determination	  of	  bacterial	  burden.	  Infected	   embryos	   were	   incubated	   at	   28°C	   for	   8	   h	   prior	   to	   re-­‐isolation.	  	  Twenty	   fish	   in	   triplicate	   treatments	  were	   thoroughly	  washed	   in	  sterile	  dPBS,	   then	  homogenized	  in	  1	  ml	  of	  L	  broth.	  	  Ten-­‐fold	  serial	  dilutions	  were	  performed	  in	  L	  broth	  and	   each	  dilution	  was	  plated	   in	  duplicate	   onto	   the	   appropriate	   selection	  medium.	  	  Plates	   were	   incubated	   at	   37°C	   for	   24	   h,	   then	   colonies	   were	   counted	   and	  
	  	  
	  39	  
corresponding	  titers	  were	  calculated.	  Bacterial	  burden	  ±	  standard	  error	  of	  the	  mean	  is	   expressed	   as	   CFUs	   per	   ml	   of	   embryo	   homogenate.	   Error	   bars	   represent	   the	  standard	  errors	  of	  the	  mean	  between	  replicates.	  	  Data	  represent	  three	  independent	  experiments.	  Statistical	  significance	  was	  determined	  by	  the	  Student’s	  t-­‐test.	  
2.3.7.	  Respiratory	  burst	  assay.	  	  	  Respiratory	  burst	  assays	  were	  performed	  as	  described	  previously	  (53),	  with	  the	   following	   modifications.	   	   Twelve	   embryos	   per	   treatment	   were	   induced	   with	  phorbol	   12-­‐myristate	   13-­‐acetate	   (PMA),	   while	   12	   remained	   uninduced.	  	  Fluorescence	  was	  measured	  using	  a	   Synergy2	  plate	   reader	   (Biotek,	  Winooski,	  VT)	  every	   2	   min	   32	   sec	   for	   a	   total	   of	   95	   measurements.	   	   Excitation	   /	   emission	  wavelengths	  were	  485	  nm	  /	  528	  nm,	  respectively.	  	  The	  95th	  measurement	  was	  used	  to	  determine	  the	  fold	  induction	  value.	   	  Error	  bars	  represent	  standard	  errors	  of	  the	  mean.	   	  Data	   represent	   three	   independent	   experiments.	   Statistical	   significance	  was	  determined	  by	  Two	  Factor	  ANOVA.	  
2.3.8.	  Neutrophil	  migration	  assay.	  	  Fifty	   bacterial	   cells	   were	   introduced	   into	   the	   hindbrain	   ventricle	   of	   10−15	  Tg(mpx:GFP)	  zebrafish	  embryos	  at	  48	  hpf	  by	  microinjection.	  Embryos	  were	  imaged	  by	  epi-­‐fluorescence	  microscopy	  at	  3	  hpi	  and	  the	  total	  number	  of	  neutrophils	  within	  the	   ventricle	   was	   counted.	   Data	   shown	   was	   collected	   in	   three	   independent	  experiments	   for	   each	   pathogen.	   42	   Cftr	   morphant	   and	   42	   control	   embryos	   were	  infected	  with	  PA14;	  35	  were	  infected	  with	  E.	  coli	  and	  30	  were	  PBS	  injected	  controls.	  Statistical	  significance	  was	  determined	  by	  the	  Student’s	  t-­‐test.	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2.3.9.	  Fluorescence	  microscopy.	  Imaging	   was	   performed	   with	   an	   Olympus	   IX-­‐81	   inverted	   epi-­‐fluorescence	  microscope	  equipped	  with	  a	  Hamamatsu	  ORCA-­‐ER	  CCD	  camera	  and	  IPLab	  software	  (BD	   Biosciences,	   Rockville,	   MD).	   Confocal	   microscopy	   was	   performed	   using	   an	  Olympus	   IX-­‐81	   equipped	  with	   an	  Olympus	   FV-­‐1000	   laser	   scanning	   confocal	   using	  the	   Olympus	   FV-­‐10	   software	   package.	   Objective	   lenses	   4x/0.16	   NA,	   10×/0.4	   NA,	  40x/0.9	  NA	  and	  100×	  oil	  immersion/1.4	  NA	  were	  used.	  	  Prior	  to	  imaging,	  fish	  were	  anesthetized	  by	  immersion	  in	  Tris-­‐buffered	  tricaine	  methane	  sulfonate	  (200	  μg/ml).	  	  Images	  represent	  overlays	  of	  wide-­‐field	  differential	  interference	  contrast	  (DIC)	  and	  fluorescence	   images	  unless	  otherwise	  noted.	   	  Optical	   filters	  providing	   excitation	  /	  emission	  at	  543	  nm	  /	  610	  nm	  and	  488	  nm	  /	  510	  nm	  were	  used	  for	  the	  detection	  of	  RFP	  and	  EGFP,	  respectively.	  	  	  	  
2.4.Results	  
2.4.1.	  Assessment	  of	  P.	  aeruginosa	  infection	  by	  microinjection.	  
P.	   aeruginosa	   infection	   by	   microinjection	   has	   been	   described	   (7,	   12).	  Injection	  into	  the	  duct	  of	  Cuvier	  (12)	  resulted	  in	  the	  dissemination	  of	  bacteria	  into	  the	  bloodstream	  and	  proved	  to	  be	  the	  most	  effective	  method	  of	  infection.	  	  	  The	  LD50	  of	  PA14	  was	  determined	  to	  be	  approximately	  50	  CFU	  /	  embryo	  (Fig.	  1a),	  resulting	  in	  50%	  mortality	   by	   48	   hpi,	   significantly	   higher	   than	   PBS-­‐injected	   controls.	   Bacteria	  initially	   colonized	   the	   yolk	   and	   spread	   to	   other	   regions	   in	   the	   fish,	   including	   the	  vasculature	  and	  tissues	  of	   the	  heart	  and	  tail,	  within	  a	   few	  hours	  post	   infection.	   	   In	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addition,	   bacteria	  were	   readily	   engulfed	   by	   professional	   phagocytes	   circulating	   in	  the	   bloodstream.	   	   Neutrophils	   of	   the	   Tg(mpx:GFP)i114	   	   zebrafish	   containing	  phagocytosed	  PA14(p67T1)	  were	  abundant	  (Fig.	  1b)	  and	  were	  observed	  primarily	  near	  the	  site	  of	  injection,	  the	  duct	  of	  Cuvier	  along	  the	  anterior	  yolk.	  	  	  	  
	  
	  Figure	   2.1.	   Zebrafish	   Are	   Infected	   by	  Microinjected	  P.	   aeruginosa.50	  CFUs	  of	  PA14	  were	  injected	  into	  the	  duct	  of	  Cuvier	  of	  48	  hpf	  fish.	  (a)	  Kaplan-­‐Meier	  survival	  curve	  showing	  approximately	  50%	  mortality	  in	  PA14	   infected	   embryos	   by	   48	   hpi	   in	   wild	   type	   AB	   zebrafish.	   This	  mortality	   is	   significantly	   higher	   than	  mock	   injected	   controls	   by	  Log-­‐Rank	  Test	  and	  by	  Wilcoxon	  (p	  <	  0.0001).	  (b)	  Red	  fluorescent	  bacteria	  (white	  arrows)	  phagocytosed	  by	  green	  fluorescent	  neutrophils	  in	  the	  Tg(mpx:GFP)i114	  transgenic	  zebrafish	  embryo.	  Scale	  bars	  represent	  10	  um.	   	   (c)	  PCR	  amplification	  of	  200	  bp	   fragment	  of	  cftr	   from	  zebrafish	  tissues.	  K:	  Kidney,	  S:	  Spleen,	  I:	  Intestine,	  V:	  Liver,	  L:	  Lymphocytes,	  M:	  Myeloid	  cells,	  C:	  No	  template	  control.	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2.4.2.	  cftr	  Expression	  in	  the	  zebrafish.	  	  
cftr	   has	  been	   cloned	  and	   characterized	   in	   several	   fish	   species	   (9)	   including	  the	  zebrafish.	  Zebrafish	  cftr	  was	  expressed	  in	  the	  liver,	  kidney,	  spleen	  and	  intestine	  (Fig.	  1c).	  cftr	  transcripts	  were	  detected	  in	  cells	  of	  the	  myeloid	  lineage	  that	  includes	  macrophages	   and	   neutrophils.	   Expression	   of	   cftr	   was	   not	   detected	   in	   the	  lymphocyte	  population.	  T-­‐cell	   receptor	  α	   (TCRα)	   and	  mpx,	  which	  are	  expressed	   in	  zebrafish	   T	   lymphocytes	   and	   neutrophils,	   respectively,	   were	   used	   as	   controls	   to	  ensure	  the	  purity	  of	  cDNA	  derived	  from	  lymphocytes	  and	  myeloid	  cells.	  Expression	  levels	  of	  β-­actin	  were	  consistent	  in	  all	  tissues	  examined.	  




	  Figure	   2.2.	   Dampened	  Respiratory	  Burst	   Response	   in	   Cftr	  Morphant	  Embryos.	   At	   48	   and	   56	   hpf	   respiratory	   burst	   is	   significantly	  dampened	   in	   morphant	   embryos	   versus	   controls,	   indicating	   a	  decrease	   in	   production	   of	   ROS	   in	   morphants.	   Results	   are	  representative	   of	   three	   independent	   experiments.	   	   Error	   bars	  represent	   standard	   errors	   of	   the	   mean.	   Statistical	   significance	   was	  determined	  by	  Two	  Factor	  ANOVA.	  	  
	   2.4.4.	  Delayed	  neutrophil	  migration	  in	  Cftr	  morphants.	  	  With	   the	   finding	   that	   Cftr	   knockdown	   disrupts	   overall	   immune	   health	   by	  reducing	  ROS	  production,	  directed	  chemotaxis	  of	  neutrophils	  to	  a	  localized	  infection	  was	   assessed	   in	   the	   zebrafish.	   At	   48	   hpf,	   PA14(p67T1)	   was	   injected	   into	   the	  hindbrain	  ventricle	  (HBV),	  as	  described	  by	  Davis	  et	  al(22),	  of	  morphant	  and	  control	  Tg(mpx:GFP)i114	   	   transgenic	   embryos.	   Neutrophils	   began	   to	   arrive	   at	   the	   site	   of	  infection	   at	   90	   minutes	   post	   infection	   (mpi)	   with	   peak	   migration	   at	   180	   mpi.	  Neutrophils	  in	  the	  HBV	  were	  enumerated	  at	  180	  mpi	  (Fig.	  3a).	  The	  average	  number	  of	  neutrophils	  in	  the	  HBV	  of	  Cftr	  morphants	  (9	  cells)	  was	  significantly	  lower	  than	  in	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infected	  controls	  (15	  cells)	  (Fig.	  3b).	  Upon	  infection	  with	  avirulent	  E.	  coli,	  an	  average	  of	   5	   neutrophils	   arrived	   at	   the	   HBV	   at	   180	   mpi	   and	   there	   was	   no	   significant	  difference	   between	   the	   morphants	   and	   controls	   (Fig.	   3b).	   The	   perturbation	   in	  migration	   behavior	   of	   neutrophils	   in	   response	   to	   a	   P.	   aeruginosa	   infection	   may	  account	   for	   the	   reduced	  clearance	  of	   the	  bacteria	   in	   the	  Cftr	  morphants	  discussed	  below.	  	  	  
	  








2.4.5.	  Bacterial	  burden	  in	  Cftr	  morphants.	  One	   of	   the	   most	   significant	   observations	   in	   CF	   models	   is	   that	   mutated	   or	  deficient	   CFTR	   results	   in	   increased	   host	   colonization	   (15),	   and	   an	   inability	   of	   the	  host	   to	   clear	  P.	  aeruginosa	   infection	   (48,	  129).	  This	  observation,	  however,	  has	  not	  been	  obtained	  consistently	  and	  appears	  to	  depend	  on	  experimental	  design.	  	  One	  aim	  of	   this	   study	  was	   to	  determine	   if	   a	  Cftr	   knockdown	  would	  affect	   the	   ability	  of	   the	  zebrafish	  host	   to	   clear	  a	  P.	  aeruginosa	   infection.	   	  At	  48	  hpf,	  morphant	  and	  control	  embryos	  were	  microinjected	  with	  50	  CFUs	  of	  PA14	  into	  the	  duct	  of	  Cuvier.	  	  After	  8	  h	  the	  morphant	   embryos	   exhibited	   a	  bacterial	   burden	   that	  was	   significantly	   greater	  than	   that	   in	   control	   embryos,	   8.45	  ±	  0.98	   x	   103	  CFU/ml,	   versus	  2.45	  ±	  0.65	   x	   103	  CFU/ml,	   respectively	   (Fig.	   4a).	   Interestingly,	   the	   significantly	   higher	   bacterial	  burden	  early	  in	  the	  course	  of	  infection	  did	  not	  result	  in	  higher	  mortality	  in	  the	  Cftr	  morphants	   compared	   to	   the	   controls	   (data	   not	   shown).	   A	   rescue	   experiment	  was	  performed,	  wherein	  co-­‐injection	  of	   the	  CFTR	   I1E2	  morpholino	  with	   the	   full	   length	  transcript	  of	  zebrafish	  cftr	  confirmed	  that	  the	  effect	  of	  morpholino	  knockdown	  was	  specific.	  Infection	  of	  the	  rescued	  Cftr	  morphants	  with	  PA14	  resulted	  in	  no	  significant	  difference	  in	  bacterial	  burden	  when	  compared	  with	  the	  controls,	  3.43	  ±	  0.76	  x	  103	  CFU/ml	  versus	  2.80	  ±	  0.5	  x	  103	  CFU/ml,	  respectively	  (Fig.	  4b).	  	  	  To	  visually	  confirm	  the	  increased	  bacterial	  burden,	  morphant	  embryos	  were	  challenged	  with	  PA14(p67T1).	   	  At	  8	  hpi,	  20	  fish	  were	  selected	  at	  random	  from	  the	  control	   and	  morphant	   groups	  and	  examined	  by	   fluorescence	  microscopy.	   	  Greater	  fluorescence	   signal	   intensity	   was	   observed	   in	   the	   Cftr	   morphants	   compared	   to	  
	  	  
	  47	  
controls,	  and	  this	  fluorescence	  was	  most	  apparent	  within	  the	  yolk	  (Figs.	  4c	  and	  4d).	  We	   have	   previously	   shown	   that	   RFP-­‐expressing	   and	   wild-­‐type	   strains	   of	   P.	  
aeruginosaare	   equally	   virulent,	   and	   that	   the	   production	   of	   RFP	   has	   no	   effect	   on	  bacterial	  burden(134).	  
2.4.6.	  Increased	  bacterial	  burden	  is	  unique	  to	  P.	  aeruginosa.	  	  Cftr	  morphant	  embryos	  have	  a	  3.5	  fold	  higher	  number	  of	  PA14	  cells	  after	  8	  h	  of	   infection	   than	   do	   control	   embryos.	   To	   determine	   if	   this	   finding	  was	   unique	   to	  PA14,	   the	   bacterial	   burden	   assay	   was	   repeated	   with	   a	   CF	   clinical	   isolate	   of	   P.	  




	  Figure	   2.5.	   Increased	   Bacterial	   Burden	   in	   Cftr	  Morphants	   Is	   Specific	  for	   P.	   aeruginosa.	   Infection	   of	   Cftr	   morphants	   with	   PA14	   shows	   a	  statistically	   significant	   3.47-­‐fold	   change	   in	   bacterial	   burden	   over	  control.	  P.	  aerigoinosa	  clinical	  isolate	  SCM573	  shows	  a	  similar	  2.9-­‐fold	  higher	  bacterial	  burden	  in	  morphants	  compared	  to	  controls.	  Infection	  of	  morphants	  with	  Edwardsiella	   tarda,	   Escherichia	   coli,	   Burkholderia	  
cenocepacia,	  Staphylococus	  aureus	  and	  Haemophilus	  influenzae	  shows	  no	   significant	   change	   in	   bacterial	   load	   over	   controls.	   Results	   are	  representative	   of	   three	   independent	   experiments.	   	   Error	   bars	  represent	  standard	  errors	  of	  the	  mean.	  	  
2.4.7.	   LasR	   quorum	   sensing	   regulator	   but	   not	   Type	   III	   Secretion	   is	  
required	  for	  increased	  virulence	  in	  Cftr	  morphants.	  The	  Type	  III	  Secretion	  System	  (T3SS)	  and	  LasR	  have	  been	  previously	  shown	  to	   be	   important	   virulence	   determinants	   in	  P.	   aeruginosa	   infection	   in	   zebrafish	   (7,	  12).	   The	   connection	   between	   these	   systems	   and	   the	   reduced	   clearance	   of	   P.	  
aeruginosa	  in	  the	  Cftr	  morphants	  was	  examined.	  Infection	  with	  PA14	  ∆T3SS	  in	  Cftr	  morphants	   resulted	   in	   a	   4-­‐fold	   increase	   in	   the	   bacterial	   burden,	   similar	   to	   that	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observed	  with	  wild	   type	   PA14,	   compared	   to	   control	   embryos	   (Fig.	   6),	   though	   the	  total	   number	   of	   bacteria	   recovered	   was	   significantly	   higher	   than	   with	   wild	   type	  PA14.	  Upon	  infection	  with	  PA14	  ∆LasR,	  bacterial	  burden	  in	  the	  Cftr	  morphants	  was	  similar	  to	  that	  of	  the	  controls	  (Fig.	  6)	  and	  the	  number	  of	  bacteria	  recovered	  at	  8	  hpi	  was	   consistent	   with	   that	   of	   wild	   type	   PA14,	   approximately	   2	   x	   103	   CFU/ml,	  suggesting	   that	   components	  of	   the	  LasR	  system,	  not	  T3SS,	  may	  be	   responsible	   for	  the	  reduced	  bacterial	  clearance	  in	  morphants.	  
	  
	  
	  Figure	   2.6.LasR	   contributes	   to	   the	   Reduced	   Bacterial	   Clearance	   of	   P.	  
aeruginosa	   in	   Cftr	   Morphant	   Zebrafish	   Embryos.	   48	   hour	   post	  fertilization	  morphant	   and	   control	   embryos	  were	   challenged	  with	   50	  CFUs	   of	   PA14	   mutants	   defective	   in	   either	   T3SS	   or	   the	   LasR	  transcriptional	   regulator	   and	   incubated	   8	   hours.	   	  Morphant	   embryos	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infected	   with	   the	   T3SS	   mutant	   exhibit	   a	   4.5-­‐fold	   greater	   bacterial	  burden	  than	  controls.	  No	  difference	  in	  bacterial	  burden	  was	  observed	  upon	  infection	  with	  PA14	  defective	  in	  LasR.	  Results	  are	  representative	  of	   three	   independent	   experiments.	   	   Error	   bars	   represent	   standard	  errors	  of	   the	  mean,	   statistical	   significance	  determined	  by	  Student’s	   t-­‐test.	  	  
2.5.	  Discussion	  In	  this	  zebrafish	  study,	  Cftr	  knockdown	  during	  acute	  P.	  aeruginosa	   infection	  resulted	  in	  a	  greater	  bacterial	  burden,	  observed	  at	  8	  hpi.	  The	  trend	  of	  reduced	  early	  clearance	  of	  P.	  aeruginosa	  has	  been	  demonstrated	  previously	  in	  mice	  (129),	  where	  differences	   between	   CFTR	   knockout	   and	   control	   mice	   were	   only	   observed	   a	   few	  hours	   post	   infection.	   This	   study,	   however,	   has	   generated	   controversy	   (11).	   Our	  findings	  were	  not	  strain-­‐specific	  and	  were	  noted	  in	  morphants	  infected	  with	  PA14,	  the	   constitutive	   RFP-­‐expressing	   PA14(p67T1)	   and	   a	   CF	   clinical	   isolate	   SMC573.	  Rescue	  experiments,	   in	  which	   the	  knockdown	  of	  Cftr	  was	   complemented	  with	   full	  length	   transcripts	   of	   the	   gene,	   showed	   no	   measureable	   difference	   in	   bacterial	  burden	  compared	  to	  controls,	  confirming	  that	  the	  findings	  are	  a	  direct	  result	  of	  Cftr	  knockdown.	  	  
P.	  aeruginosa	  is	  only	  one	  of	  the	  several	  species	  of	  bacteria	  commonly	  isolated	  from	  sputum	  of	  CF	  patients.	  S.	  aureusand	  H.	  influenzae	  are	  typically	  associated	  with	  early	   childhood	   infections	   in	   CF,	   usually	   before	   P.	   aeruginosa	   becomes	   prevalent	  (16,	   45,	   60,	   87,	   151),	   and	   infections	  with	   B.	   cepacia	   complex	   are	   often	   associated	  with	   a	   very	   poor	   clinical	   outcome	   (128).	   We	   determined	   the	   effect	   of	   Cftr	  knockdown	   on	   bacterial	   clearance	   by	   the	   host.	   The	   bacteria	   observed	   included	  E.	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tarda,	   a	  natural	   fish	  pathogen	   that	  has	  been	  previously	  described	   in	   the	   zebrafish	  (113),	   an	   avirulent	   strain	   of	   E.	   coli,	   XL-­‐10,	   and	   S.	   aureus,	   H.	   influenzae	   and	   B.	  
cenocepacia,	  which	  are	  common	  CF	  lung	  pathogens.	  Clearance	  was	  examined	  under	  identical	   infection	   conditions	   and	   no	   significant	   difference	   in	   bacterial	   burden	  between	  Cftr	  morphants	  and	  controls	  was	  observed	  at	  8	  hpi,	  providing	  evidence	  of	  Cftr-­‐mediated	   specific	   resistance	   to	   P.	   aeruginosa.	   These	   findings	   indicate	   that	  although	  Cftr	  is	  required	  for	  the	  initial	  innate	  immune	  response	  to	  P.	  aeruginosa,	  it	  is	  not	   required	   for	   response	   to	   other	   bacterial	   pathogens,	   including	   other	   common	  respiratory	  pathogens	  and	  those	  that	  naturally	  infect	  the	  zebrafish.	  	  Two	  mechanisms	  of	  virulence	  most	  commonly	  associated	  with	  P.	  aeruginosa	  pathogenesis	   were	   examined	   as	   possible	   contributors	   to	   the	   impaired	   bacterial	  clearance	  observed	   in	   the	  Cftr	  morphants.	  The	  T3SS	  plays	  a	   significant	   role	   in	   the	  progression	   of	   infection,	   and	   P.	   aeruginosa	  mutants	   defective	   in	   T3SS	   have	   been	  shown	  previously	   to	   have	   an	   impaired	   ability	   to	   infect	   zebrafish	   embryos	   (7,	   12).	  Infection	  with	  PA14	  ΔT3SS	  resulted	  in	  the	  same	  trend	  as	  wild	  type	  PA14,	  indicating	  that	   even	   though	   T3SS	   is	   an	   important	   virulence	   determinant	   in	  P.	   aeruginosa,	   it	  does	  not	  influence	  impaired	  clearance	  in	  the	  morphants.	  The	  LasR	  transcriptional	  regulator	  is	  key	  to	  quorum	  sensing	  in	  P.	  aeruginosa	  and	   regulates	   the	   expression	   of	   multiple	   virulence	   factors.	   According	   to	   one	  retrospective	   study,	   in	   which	   clinical	   isolates	   of	  P.	   aeruginosa	  were	   genotypically	  categorized,	   approximately	   30%	   of	   the	   isolates	   obtained	   from	   cystic	   fibrosis	  patients	  were	   LasR	  mutants	   (54).	   Hoffman	   and	   colleagues	   speculated	   that	   during	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chronic	  infection	  there	  is	  selective	  pressure	  for	  LasR	  mutants	  in	  the	  CF	  lung	  because	  virulence	   factors	   required	   for	   acute	   infection	   become	   disadvantageous	   for	  maintaining	  chronic	  infection.	  In	  addition,	  a	  recent	  study	  by	  this	  group	  determined	  that	  the	  mechanism	  for	  this	  selection	  lies	  in	  the	  availability	  of	  specific	  amino	  acids	  found	  in	  the	  CF	  airway,	  which	  offer	  a	  metabolic	  advantage	  to	  the	  LasR	  mutants	  (55).	  Low	   oxygen	   tension	   and	   high	   levels	   of	   nitrates	   in	   the	   lung	   favor	   utilization	   of	  nitrogen	  species	  over	  oxygen	  for	  metabolism	  by	  the	  bacteria.	  The	  authors	  show	  that	  denitrification	   by	  P.	   aeruginosa	   results	   in	   an	   accumulation	   of	  NO·,	   and	   exogenous	  sources	   of	   NO·	   overwhelm	   the	   detoxification	   processes	   by	   the	   bacterium.	   This	  makes	  P.	   aeruginosa	  LasR	  mutants	   highly	   susceptible	   to	   reactive	   nitrogen	   species	  (RNS)	  but	   confers	  a	   resistance	   to	  oxidative	   stress	   (55).	  We	   found	  no	  difference	   in	  bacterial	   burden	   between	   morphants	   and	   controls	   challenged	   with	   PA14	   ΔLasR,	  identifying	   one	   or	   more	   components	   of	   this	   complex	   system	   as	   critical	   to	   the	  enhanced	  virulence	  of	  the	  bacterium	  in	  CF.	  It	  is	  probable	  that	  although	  loss	  of	  LasR	  is	   key	   to	   survival	   during	   chronic	   infections,	   the	   transcription	   of	   virulence	   factors	  downstream	  from	  LasR	  is	  critical	  for	  the	  initial	   infection	  in	  CF.	  These	  data	  support	  the	  conclusions	  drawn	  from	  studies	  in	  the	  mouse	  CF	  model,	  which	  identified	  CFTR	  as	  a	  pattern	  recognition	  receptor	  for	  P.	  aeruginosa	  and	  show	  reduced	  early	  bacterial	  clearance	   in	   CFTR-­‐/-­‐	   mice	   (129),	   but	   offer	   an	   alternative	   explanation	   for	   the	  specificity	  observed	  between	  CFTR	  and	  P.	  aeruginosa	  early	  in	  the	  course	  of	  infection.	  Because	   only	   the	   PA14	   LasR	   mutant	   was	   examined	   in	   this	   study,	   further	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investigation	  with	  mutants	  of	  other	   strain	  backgrounds	   is	   required	   to	   confirm	   the	  role	  of	  LasR	  during	  infection.	  Respiratory	   burst	   is	   a	   key	   host	   defense	   mechanism	   against	   invading	  microorganisms.	   	   In	  vitro	   studies	  have	  recently	   revealed	   that	  CFTR	   is	   required	   for	  acidification	   of	   the	   phagosomal	   compartment	   of	   professional	   phagocytes,	   such	   as	  macrophages	  and	  neutrophils,	  and	  may	  shed	  light	  on	  the	  nature	  of	  the	  involvement	  of	   CFTR	   in	   ROS	   production	   and	   bacterial	   killing	   (30,	   32,	   98).	   This	   phagosomal	  chlorination	  defect	   is	  thought	  to	  result	   in	   impaired	  function	  of	  the	  NADPH	  oxidase	  and	  peroxidases	  due	  in	  part	  to	  an	  insufficient	  H+	  gradient	  between	  the	  lumen	  of	  the	  phagosome	   and	   the	   cytosol.	   The	   respiratory	   burst	   response	   of	   many	   organisms	  serves	  as	  a	  good	  indicator	  of	  overall	   innate	   immune	  health	  (53),	  and	  zebrafish	  are	  an	   ideal	  model	   for	   studying	   the	  dynamics	  of	   this	   response	  because	  whole-­‐embryo	  measurements	   of	   respiratory	   burst	   can	   be	   made	   in	   vivo	   (53).	   	   Respiratory	   burst	  levels	  in	  Cftr	  morphants	  were	  significantly	  lower	  than	  controls	  at	  48	  and	  56	  hpf.	  The	  56	   hpf	   time	   point	   corresponds	   to	   an	   8	   hour	   infection	   of	   48	   hpf	   embryos,	   the	  developmental	   stage	   in	   which	   the	   bacterial	   burden	   was	   greater	   in	   morphant	  embryos.	  These	  data	  suggest	  that	  Cftr	  knockdown	  in	  zebrafish	  embryos	  leads	  to	  an	  impaired	  innate	  immune	  response	  characterized	  in	  part	  by	  a	  significant	  reduction	  in	  the	  production	  of	  ROS.	  Because	   there	  was	  marked	  reduction	  of	  ROS	  production	   in	  morphant	   fish	   at	   these	   time	   points	   and	   cftr	   expression	   was	   demonstrated	   in	  zebrafish	   myeloid	   cells,	   the	   data	   could	   explain	   the	   impaired	   ability	   to	   clear	   the	  infection.	   It	   has	   been	   shown	   that	   P.	   aeruginosa	   LasR	   mutants	   are	   much	   more	  
	  	  
	  54	  
susceptible	   to	  ROS	   than	   LasR	   competent	   strains	   (55).	   The	   increased	   sensitivity	   of	  the	   bacteria	   could	   explain	   why	   the	   morphant	   embryos	   are	   as	   proficient	   as	   the	  control	   embryos	   at	   clearing	   the	   LasR	  mutants,	   despite	   the	   reduced	   production	   of	  ROS	   overall.	   	   Further	   investigation	   is	   required	   to	   determine	   the	   underlying	  mechanism	  for	  this	  observation	  and	  the	  potential	  role	  of	  RNS	  in	  bacterial	  clearance	  of	  the	  P.	  aeruginosa	  LasR	  mutant.	  The	   major	   cause	   of	   morbidity	   and	   mortality	   in	   CF	   has	   been	   attributed	   to	  destruction	   of	   the	   lung	   epithelia	   by	   a	   massive	   and	   importunate	   neutrophylic	  inflammation	   (66).	   	   Proteases	   and	   oxygen	   radicals	   released	   by	   neutrophils	   in	   an	  attempt	  to	  eradicate	  bacterial	  infection	  cause	  damage	  to	  the	  epithelial	  surface	  (35).	  One	   question	   that	   remains	   heavily	   debated	   is	   whether	   the	   inflammation	   occurs	  independently	  of	  bacterial	   infection	  or	  as	  a	  result	  of	   it.	  Observations	  of	  neutrophil	  inflammation	   in	   CF	   infants,	   where	   no	   pathogens	   were	   detected,	   have	   been	  challenged	   by	   evidence	   showing	   colonization	   of	   the	   lower	   respiratory	   tract	   at	  subclinical	  levels	  before	  presentation	  of	  symptoms	  (35).	  An	  in	  vitro	  study	  has	  shown	  a	   significant	   decrease	   in	   directed	   chemotaxis	   between	   neutrophils	   isolated	   from	  healthy	   individuals	   and	   from	   acutely	   infected	   CF	   patients	   (131).	   These	   studies,	  however,	   were	   unable	   to	   sufficiently	   answer	   the	   complex	   questions	   surrounding	  neutrophil	  recruitment	  to	  an	  infection.	  An	  advantage	  of	  the	  optically	  clear	  zebrafish	  embryo	   is	   that	   assessment	   of	   infection	   can	   be	   made	   in	   vivo	   using	   fluorescently-­‐labeled	   pathogens	   and	   established	   transgenic	   zebrafish	   lines.	   This	   makes	   the	  zebrafish	  an	   ideal	  model	   for	   the	  study	  of	  phagocyte-­‐pathogen	   interactions	  and	  the	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kinetics	   of	   bacterial	   clearance	   in	   vivo,	   which	   is	   not	   easily	   conducted	   in	   mice.	  Zebrafish	  neutrophils	  demonstrate	  strong	  chemotaxis	  toward	  wound	  and	  infection	  sites	   (69)	   and	   actively	   engulf	   invading	   pathogens.	   A	   transgenic	   line	   of	   zebrafish	  expressing	   GFP	   in	   neutrophils,	   Tg(mpx:GFP)i114	   ,	   	   under	   the	   control	   of	   the	  myeloperoxidase	  promoter,	  has	  been	  characterized	   (123).	   	   	  Changes	   in	  neutrophil	  behavior	   in	   embryos	   were	   assessed	   with	   imaging	   studies	   performed	   in	  Tg(mpx:GFP)i114	   	   embryos	   infected	  with	  PA14(p67T1).	  These	  experiments	   showed	  that	   a	   localized	   infection	   in	   a	   discrete	   location	   could	   be	   established	   resulting	   in	   a	  vigorous	   neutrophil	   migration	   by	   3	   hpi.	   Significantly	   fewer	   neutrophils	   were	  observed	   in	   response	   to	   the	   infection	   of	   Cftr	   morphant	   embryos	   indicating	   an	  impaired	   response	   to	   pathogens.	   E.	   coli	   XL-­‐10	   was	   used	   as	   a	   control	   and	   no	  difference	   in	   the	   number	   of	   neutrophils	   between	   morphants	   and	   controls	   was	  observed	   at	   3	   hpi.	   Fewer	   neutrophils	   migrated	   to	   the	   HBV	   because	   the	   overall	  neutrophil	   response	   to	  E.	   coli	   is	   less	   robust	   in	   zebrafish	   (69).	  This	   indicates	   some	  specificity	   in	   the	   neutrophil	   response	   or	   signaling	   to	   P.	   aeruginosa.	   Dampened	  neutrophil	  migration,	  coupled	  with	  the	  LasR-­‐dependent	  enhancement	  of	  infection	  in	  the	  Cftr	  morphants,	  offers	  an	  explanation	  as	  to	  why	  the	  CF	  lung	  is	  so	  easily	  colonized	  by	   P.	   aeruginosa,	   an	   organism	   that	   rarely	   causes	   respiratory	   tract	   infections	   in	  healthy	   individuals.	   It	   is	   possible	   that	   the	   slower,	   less	   robust	   neutrophil	   response	  may	   afford	   the	   bacteria	   more	   time	   to	   establish	   sufficient	   density	   to	   undergo	  phenotypic	   changes	   associated	  with	   LasR	   quorum	   sensing,	   rendering	   the	   bacteria	  more	  resistant	  to	  host	  defenses	  and	  allowing	  infection	  to	  persist.	  
	  	  
	  56	  





THE	  IRON	  REGULATED	  VIRULENCE	  NETWORK	  OF	  	  
PSEUDOMONAS	  AERUGINOSAPERMITS	  RAPID	  AND	  ENHANCED	  	  
COLONIZATION	  IN	  A	  ZEBRAFISH	  MODEL	  OF	  CYSTIC	  FIBROSIS	  
	  
3.1.	  Abstract	  	  Cystic	   fibrosis	   (CF)	   is	   the	   most	   common	   lethal	   hereditary	   disease	   and	   is	  caused	  by	  recessive	  mutations	   in	  the	  Cystic	  Fibrosis	  Transmembrane	  Conductance	  Regulator	   (CFTR)	   gene.	   CF	   is	   associated	   with	   multi-­‐organ	   defects	   resulting	   from	  improper	  ion	  transport	  across	  epithelial	  membranes.	  Chronic	  lung	  infection	  by	  the	  environmentally	   ubiquitous	   opportunistic	   human	   pathogen	   Pseudomonas	  
aeruginosa	  and	  the	  subsequent	  hyperinflammation	  that	  occurs	  as	  the	  host	  immune	  system	   combats	   the	   bacterium	   are	   responsible	   for	   the	   bulk	   of	   the	  morbidity	   and	  mortality	  in	  CF.	  Despite	  numerous	  studies	  that	  have	  sought	  to	  elucidate	  the	  role	  of	  CFTR	  in	  the	  innate	  immune	  response,	  the	  links	  between	  CFTR,	  innate	  immunity,	  and	  
P.	   aeruginosa	   infection	   remain	  unclear.	  Our	  previous	  work	  has	  demonstrated	   that	  zebrafish	   embryos	   with	   reduced	   expression	   of	   the	   cftr	   gene	   (Cftr	   morphants)	  exhibited	   reduced	   respiratory	   burst	   response,	   directed	   neutrophil	   migration	   and	  had	   a	   reduced	   ability	   to	   clear	   P.	   aeruginosa	   infections,	   a	   phenomenon	   that	   was	  unique	   to	   this	   pathogen	   and	   was	   caused	   by	   virulence	   factors	   regulated	   through	  quorum	  sensing	  (QS).	  The	  present	  work	  highlights	  our	  ability	  to	  use	  the	  zebrafish	  to	  model	  and	  elucidate	  mechanisms	  of	  infection	  by	  replicating	  multiple	  facets	  of	  the	  CF	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condition	  in	  humans.	  In	  this	  study,	  Cftr	  morphants	  were	  infected	  with	  P.	  aeruginosa	  mutants	   defective	   in	   the	   expression	   of	   QS	   regulated	   virulence	   factors.	   A	   mutant	  defective	   in	   the	   production	   of	   Exotoxin	   A	   	   (ETA)	   resulted	   in	   similar	   bacterial	  clearance	  in	  both	  the	  Cftr	  morphant	  and	  control	  embryos.	  The	  reduction	  in	  directed	  neutrophil	  migration	  to	  a	  P.	  aeruginosa	  infection	  was	  also	  restored	  when	  challenged	  with	  the	  ETA	  mutant.	  Cftr	  morphants	  were	  found	  to	  display	  a	  statistically	  significant	  iron	  deficiency	  (ID)	  compared	  to	  control	  embryos,	  a	  symptom	  commonly	  diagnosed	  in	   humans	   with	   CF	   that	   is	   believed	   to	   be	   a	   result	   of	   deficiencies	   in	   pancreatic	  function	   and	   poor	   nutrient	   uptake.	   Taken	   together,	   these	   data	   point	   towards	   a	  possible	  explanation	  for	  the	  specificity	  between	  P.	  aeruginosa	  and	  CF.	  The	  zebrafish	  system	  provides	  a	  multitude	  of	  advantages	  for	  studying	  the	  unique	  pathophysiology	  resulting	   from	   defective	   expression	   of	   cftr,	   the	   pathogenesis	   of	  P.	   aeruginosa	   and	  elucidating	   the	   role	   that	   the	  CF	   innate	   immune	   system	  plays	   in	   response	   to	   acute	  bacterial	  infections.	  	  
3.2.	  Introduction	  	  Cystic	   fibrosis	   (CF)	   is	   a	   lethal	   hereditary	   multi-­‐organ	   disorder	   caused	   by	  mutations	   in	  the	  Cystic	  Fibrosis	  Transmembrane	  Conductance	  Regulator	  (CFTR),	  a	  chloride	  ion	  channel	  expressed	  in	  most	  epithelial	  cells	  in	  the	  body	  (28).	  Thick	  mucus	  produced	   by	   all	   mucosal	   surfaces,	   a	   symptom	   of	   poor	   ion	   transport	   across	   these	  membranes,	   is	   responsible	   for	  many	   of	   the	   clinical	  manifestations	   of	   this	   disease.	  Poor	   pancreatic	   function	   and	   thick	   mucus	   blocking	   the	   intestinal	   tract	   results	   in	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poor	  uptake	  of	  nutrients,	  vitamins	  and	  minerals.	   Iron	  deficiency	  (ID),	  and	  often	  ID	  associated	   anemia,	   is	   common	   in	   CF	   patients	   and	   has	   been	   attributed	   to	   poor	  pancreatic	   function	   and	   loss	   of	   iron	   into	   the	   airway	   caused	  by	   excessive	   infection	  and	  inflammation	  (46).	  	  The	  bulk	  of	  morbidity	  and	  mortality	  among	  people	  with	  CF	  results	   from	  chronic	  persistent	  bacterial	   infections	  of	   the	   respiratory	   tract	   caused	  primarily	  by	  the	  opportunistic	  pathogen	  Pseudomonas	  aeruginosa.	  P.	  aeruginosa	  is	  a	  common	   cause	   of	   nosocomial	   infections	   and	   is	   particularly	   problematic	   for	   ICU	  patients	   with	   implanted	   devices	   such	   as	   breathing	   tubes	   and	   catheters	   (143).	  Despite	   the	   frequent	   isolation	   of	   this	   bacterium	   in	   immunocompromised	  patients,	  infections	   by	   P.	   aeruginosa,	   particularly	   infections	   of	   the	   respiratory	   tract,	   are	  extremely	  rare	  in	  otherwise	  healthy	  individuals	  (79).	  Scientists	  and	  clinicians	  have	  sought	   to	   elucidate	   the	   factors	   that	   make	   CF	   patients	   particularly	   vulnerable	   to	  chronic	   infections	   by	   P.	   aeruginosa,	   but	   decades	   of	   research	   have	   failed	   to	   fully	  explain	  the	  mechanisms	  underlying	  this	  unique	  susceptibility.	  	  
P.	   aeruginosa	   is	   an	   environmentally	   ubiquitous	   Gram-­‐negative	   bacterium	  that	   is	   found	   in	   soil	   and	   water.	   This	   environmental	   microbe	   is	   also	   a	   common	  opportunistic	   pathogen	   in	   both	   plants	   and	   animals	   (79).	   Because	   of	   the	   diverse	  environments	   in	   which	   P.	   aeruginosa	   thrives	   and	   the	   highly	   recombinant	   and	  promiscuous	   nature	   of	   the	   bacterium,	   a	   wide	   array	   of	   potent	   toxins	   and	   other	  virulence	  factors	  are	  encoded	  within	  its	  genome.	  Cell-­‐to-­‐cell	  communication,	  or	  QS,	  has	   been	   implicated	   in	   the	   gene	   regulatory	   networks	   of	   many	   bacterial	   species	  (155),	   and	   it	   was	   not	   surprising	   that	   the	   regulation	   of	   virulence	   genes	   by	   P.	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aeruginosa	   was	   traced	   back	   to	   these	   QS	   networks	   (102).	   P.	   aeruginosa	   possesses	  two	  QS	  controlled	   transcriptional	   regulators,	  LasR	  and	  RhlR.	  These	  regulators	  and	  the	   specific	   inducers	   that	  activate	   them	  have	  been	   implicated	   in	   the	  expression	  of	  multiple	  genes	  associated	  with	  pathogenicity	  and	  toxicity	  during	  infection	  in	  plants	  and	  animals	  (See	  Figure	  1.2	  and	  Table	  1.1)	  (102).	  Recent	   studies	   have	   highlighted	   the	   zebrafish	   (Danio	   rerio)	   as	   a	   powerful	  model	  for	  studying	  host–pathogen	  interactions	  during	  bacterial	  and	  viral	  infections	  and	  the	  pathogenicity	  of	  P.	  aeruginosa	   in	  the	  zebrafish	  embryo	  has	  been	  described	  (22,	  52,	  75,	  84-­‐86,	  94,	  95,	  103,	  113,	  123,	  149,	  160).	  Our	  previous	  study	  established	  the	   zebrafish	   embryo	   as	   a	   useful	   model	   for	   studying	   the	   unique	   relationship	  between	   the	   CFTR	   and	   bacterial	   infections	   (104).	   We	   found	   that	   embryos	   with	  reduced	   expression	   of	   Cftr	   (Cftr	   morphants)	   had	   an	   enhanced	   susceptibility	   to	  infection	  by	  P.	  aeruginosa.	  Cftr	  morphants	  had	  a	  less	  robust	  neutrophil	  response	  to	  
P.	   aeruginosa,	   and	   the	   bacterial	   clearance	   defect	   in	   the	   Cftr	   morphants	   was	   the	  result	  of	  virulence	  factors	  regulated	  through	  the	  LasR	  Quorum	  Sensing	  (QS)	  system.	  	  In	  the	  present	  study,	  we	  sought	  identify	  which	  QS	  regulated	  virulence	  factors	  were	  directly	  responsible	  for	  the	  reduced	  ability	  of	  the	  morphants	  to	  clear	  infections	  caused	  by	  P.	  aeruginosa	  and	  to	  attempt	  to	  elucidate	  the	  underlying	  mechanisms	  that	  are	  responsible	  for	  this	  unique	  susceptibility.	  We	  performed	  infection	  studies	  using	  
P.	   aeruginosa	   PA14	   transposon	   insertion	   mutants	   defective	   in	   the	   expression	   of	  virulence	  factors	  that	  have	  been	  (i)	  identified	  as	  important	  for	  full	  virulence	  during	  infections,	  (ii)	  highlighted	  for	  their	  involvement	  in	  the	  pathogenicity	  of	  P.	  aeruginosa	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in	   the	   CF	   lung,	   and	   (iii)	   controlled	   by	   either	   the	   LasR	   or	   RhlR	   QS	   system	   of	   P.	  
aeruginosa.	  We	  have	  identified	  P.	  aeruginosa	  Exotoxin	  A	  (ETA)	  as	  being	  responsible	  for	   the	   reduced	   clearance	   observed	   in	   the	   Cftr	   morphant	   zebrafish	   embryos	   and	  have	  found	  that	  neutrophil	  migration	  to	  this	  mutant	  is	  restored	  to	  levels	  equal	  to	  the	  control	  embryos.	  The	  lethal	  effects	  of	  P.	  aeruginosa	  ETA	  on	  the	  host	  during	  infection	  have	  been	  well	  characterized	  (101,	  159)	  and	  the	  mechanisms	  by	  which	  the	  toxin	  is	  regulated	  have	  been	  thoroughly	  described	  (43,	  44).	  The	  present	  study	  highlights	  the	  advantages	   of	   the	   zebrafish	   embryo	   for	   infectious	   disease	   research.	   Large	   scale	  studies	   involving	   multiple	   strains	   of	   bacteria	   and	   bacterial	   mutants	   with	   varying	  pathogenicity	  are	  technically	  easy	  and	  relatively	  inexpensive	  to	  perform	  in	  zebrafish	  embryos	   and	   a	   myriad	   of	   reports	   are	   available	   demonstrating	   that	   the	   immune	  response	  of	  zebrafish	  embryos	   to	  bacterial	  pathogens	  closely	  mirrors	  experiments	  performed	  in	  murine	  models	  (146).	  The	  data	  presented	  here	  provide	  insight	  into	  a	  potential	  molecular	  mechanism	   that	   results	   in	   the	   susceptibility	   of	   CF	   patients	   to	  infection	   by	  P.	   aeruginosa	   and	   identifies	   a	   new	   avenue	   for	   future	   research	   in	   this	  field.	  	  
3.3.	  Materials	  and	  methods	  
3.3.1.	  Zebrafish	  care	  and	  maintenance	  Zebrafish	   were	   housed	   at	   the	   University	   of	   Maine	   Zebrafish	   Facility	   in	   a	  recirculating	   system	   (Aquatic	   Habitats,	   Apopka,	   FL).	   	   Water	   temperature	   was	  maintained	   at	   28°C	   with	   a	   total	   system	   flow	   rate	   of	   150	   L/min.	   	   Zebrafish	   were	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maintained	   in	   accordance	   with	   the	   Institutional	   Animal	   Care	   and	   Use	   Committee	  standards.	  	  Adult	  zebrafish	  (>3	  months	  old)	  were	  used	  for	  breeding	  embryos	  which	  were	   reared	   in	   Petri	   dishes	   containing	   60	  mL	   of	   Egg	  water	   (60	   µg	   Instant	   Ocean	  (Spectrum	   Brands)/ml).	   Strains	   used	   were	   Wild	   Type	   AB	   and	   the	   transgenic	   AB	  strain	   Tg(mpx:GFP)i114	   expressing	   enhanced	   green	   fluorescent	   protein	   (EGFP)	  driven	  by	  the	  neutrophil	  specific	  myeloperoxidase	  promoter	  (123),	  kindly	  provided	  by	  Dr.	  Stephen	  Renshaw	  (University	  of	  Sheffield,	  Sheffield,	  UK).	  Until	  24	  hours	  post	  fertilization	  (hpf),	  Egg	  water	  was	  supplemented	  with	  0.3	  mg	  of	  methylene	  blue/L	  to	  prevent	  fungal	  growth.	  	  Egg	  water	  was	  changed	  daily.	  
3.3.2.	  Morpholino	  knockdown	  Morpholino	   antisense	   oligonucleotides	   (MOs)	   against	   zebrafish	   Cftr	  (GenBank	   accession	   no.	   NM_001044883)	   were	   synthesized	   by	   Gene	   Tools	  (Philomath,	  OR),	   reconstituted,	   and	   stored	   in	  Danieau’s	  buffer.	  CFTR	   I1E2	  MO	  (5’-­‐CCACCTGTAAATATTCAGAGCAGAT-­‐3’)	  anneals	   to	   the	   intron	  1/exon	  2	  boundary	  of	  the	   transcript	   and	   results	   in	   the	   deletion	   of	   exon	   2.	   	   CFTR	   Trans	   MO	   (5’-­‐CATCCTCCACAGGTGATCTCTGCAT-­‐3’)	   anneals	   to	   the	   AUG	   start	   site	   and	   blocks	  translation.	  Cftr	  knockdown	  was	  achieved	  by	  co-­‐injecting	  1.25	  ng	  of	  each	  CFTR	  MO	  per	   embryo.	   Two	   and	   one	   half	   nanograms	   of	   Standard	   Control	  Morpholino	   (Gene	  Tools,	   Philomath,	   OR)	   was	   injected	   per	   control	   embryo.	   	   Prior	   to	   injection,	   MO	  solutions	   were	   supplemented	   with	   0.01%	   phenol	   red	   to	   permit	   visualization.	  	  Zebrafish	   embryos	   at	   the	   1–2	   cell	   stage	  were	   disinfected	   by	   rinsing	  with	   Perosan	  (Zep	  Manufacturing,	  Atlanta,	  GA)	  for	  1	  minute,	  then	  microinjected	  with	  5	  nL	  of	  MO	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solution	   in	   the	  yolk,	  using	  an	  MPPI-­‐2	  pressure	   injection	  system	  (Applied	  Scientific	  Instrumentation,	  Eugene,	  OR).	  	  
3.3.3.	  Bacterial	  strains	  and	  growth	  conditions	  Wild-­‐type	   non-­‐mucoid	   P.	   aeruginosa	   strain	   PA14and	   mariner	   transposon	  PA14	  mutants	  of	   lasA,	   lasB,	  hplS,	  mvfR,	   rhlA,phzM	   and	   toxA	   (described	  by	  Liberati,	  2005)	   were	   generously	   provided	   by	   Dr.	   George	   A.	   O’Toole	   (Dartmouth	   Medical	  School,	  Hanover,	  NH).	  P.	  aeruginosa	  strains	  were	  grown	  on	  cetrimide	  selective	  agar	  (Accumedia,	   Lansing	   MI).	   Mariner	   cultures	   were	   supplemented	   with	   30	   µg	   of	  gentamicin/ml.	  Prior	  to	  infection	  experiments,	  liquid	  cultures	  were	  grown	  for	  12	  h	  at	   37°C	   with	   shaking	   (250	   rpm)	   in	   L-­‐broth	   (USB,	   Cleveland,	   OH),	   harvested	   by	  centrifugation	   and	  washed	   twice	   in	   Dulbecco’s	   phosphate	   buffered	   saline	   (dPBS).	  Cell	  density	  was	  determined	  spectrophotometrically	  and	  adjusted	  to	  107	  CFU/ml	  in	  dPBS.	  
3.3.4.	  Identification	  of	  transposon	  insertion	  site	  in	  PA14	  mutants.	  
	   The	   location	   of	   the	   transposon	   insertion	   was	   identified	   as	   previously	  described(73).	   Briefly,	   overnight	   cultures	   of	   each	   mutant	   were	   grown	   in	   L-­‐Broth	  with	  30	  μg	  of	  gentamicin/mland	  lysed	  at	  95°C	  for	  15	  min.	  Cell	  debris	  was	  pelleted	  by	   centrifugation	   and	  5	   μl	   of	   supernatant	  were	   used	   as	   template	   for	   a	   two	   round	  PCR	   reaction	   with	   a	   transposon	   specific	   primer	   and	   an	   arbitrary	   primer	   as	  described.	   PCR	   products	   from	   the	   second	   round	   were	   gel	   extracted	   using	   the	  MiniElute	   Gel	   Extraction	   kit	   (Qiagen),	   ligated	   into	   pGEM-­‐T	   easy	   (Promega)	   and	  sequenced	   by	   the	   University	   of	   Maine	   DNA	   Sequencing	   Facility	   (Orono,	   ME).	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Sequencing	  results	  were	  blasted	  against	  the	  PA14	  genome	  using	  the	  Pseudomonas	  Genome	   Database(157).	   In	   three	   mutants,	   PA14ΩAprA,	   PA14ΩPlcB	   and	  PA14ΩPvdD,	   fragments	   could	  not	  be	  amplified	   through	   the	  arbitrary	  PCR	  method.	  For	   confirmation	   that	   the	   two	   step	  method	  was	  not	   biased	   against	   these	   genomic	  regions,	   the	   entire	   ORF	   was	   amplified	   through	   standard	   PCR	   methods	   and	   the	  fragment	  was	  sequenced	  and	  compared	  to	  wild	  type	  PA14.	  
3.3.5.	  Infection	  by	  microinjection	  At	  48	  hpf,	  zebrafish	  embryos	  were	  manually	  dechorionated	  and	  anesthetized	  by	   immersion	   in	   Tris-­‐buffered	   tricaine	  methane	   sulfonate	   (200	   µg/mL)	   (Western	  Chemicals,	   Inc.,	   Ferndale,	   WA).	   	   Unless	   otherwise	   noted,	   approximately	   5	   nl	   of	  bacterial	   suspension	   was	   microinjected	   into	   the	   duct	   of	   Cuvier	   as	   described	   by	  Clatworthy	  et	  al.(12)	  using	  the	  injection	  system	  described	  above.	  Inocula	  of	  50	  CFU	  per	  fish	  were	  injected	  into	  embryos	  for	  infection	  experiments	  with	  all	  P.	  Aeruginosa	  mutant	  strains.	  	  
3.3.6.	  Determination	  of	  bacterial	  burden	  Infected	   embryos	   were	   incubated	   at	   28°C	   for	   8	   h	   prior	   to	   re-­‐isolation.	  	  Twenty	   fish	   in	   triplicate	   treatments	  were	   thoroughly	  washed	   in	  sterile	  dPBS,	   then	  homogenized	  in	  1	  ml	  of	  L	  broth.	  	  Ten-­‐fold	  serial	  dilutions	  were	  performed	  in	  L	  broth	  and	  each	  dilution	  was	  plated	  in	  duplicate	  onto	  Cetrimide	  agar	  (Accumedia,	  Lansing	  MI)	  for	  selection	  of	  only	  P.	  aeruginosa.	  After	  a	  24	  h	  incubation	  at	  37°C,	  colonies	  were	  counted	   and	   corresponding	   titers	   were	   calculated.	   Data	   is	   expressed	   as	   either	  bacterial	  burden	  ±	  standard	  error	  of	  the	  mean	  per	  ml	  of	  embryo	  homogenate	  or	  the	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fold	  difference	  in	  burden	  of	  the	  Cftr	  morphant	  embryos	  relative	  to	  control	  embryos.	  Error	  bars	  represent	  the	  standard	  errors	  of	  the	  mean	  between	  replicates.	  	  Data	  are	  representative	   of	   three	   independent	   experiments.	   Statistical	   significance	   was	  determined	  by	  the	  Student’s	  t-­‐test.	  
3.3.7.	  Neutrophil	  migration	  assay	  Fifty	   bacterial	   cells	   were	   introduced	   into	   the	   hindbrain	   ventricle	   of	   15–20	  Tg(mpx:GFP)	  zebrafish	  embryos	  at	  48	  hpf	  by	  microinjection.	  Embryos	  were	  imaged	  by	  epi-­‐fluorescence	  microscopy	  at	  3	  hpi	  and	  the	  total	  number	  of	  neutrophils	  within	  the	   ventricle	   was	   counted.	   Data	   shown	   were	   collected	   in	   three	   independent	  experiments	   and	   pooled	   together.	   Statistical	   significance	   was	   determined	   by	   the	  Student’s	  t-­‐test.	  
3.3.8.	  Fluorescence	  microscopy	  For	  all	  microscopy	  experiments,	  an	  Olympus	  IX-­‐81	  inverted	  epi-­‐fluorescence	  microscope	   equipped	   with	   a	   Hamamatsu	   ORCA-­‐ER	   CCD	   camera	   and	   Olympus	  CellSens	   Dimension	   Software.	   Objective	   lenses	   4x/0.16	   NA,	   10×/0.4	   NA	  and20x/0.75	  NA	  were	  used.	  	  Prior	  to	  imaging,	  fish	  were	  anesthetized	  by	  immersion	  in	  Tris-­‐buffered	   tricaine	  methane	   sulfonate	   (200	  μg/ml).	   	  Optical	   filters	  providing	  excitation	  /	  emission	  at	  543	  nm	  /	  610	  nm	  and	  488	  nm	  /	  510	  nm	  were	  used	  for	  the	  detection	  of	  AlexaFlour594	  and	  EGFP,	  respectively.	  
3.3.9.	  Ferrozine	  based	  iron	  assay	  A	  ferrozine	  based	  assay	  wasperformed	  as	  previously	  described	  by	  Riemer,	  et	  
al.,	  2004,	  with	  slight	  modification.	  In	  brief,	  one	  zebrafish	  embryo	  was	  euthanized	  in	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a	  lethal	  dose	  of	  tricaine	  methane	  sulfonate,	  transferred	  to	  a	  0.7	  ml	  microcentrifuge	  tube	  and	  lysed	  for	  1	  hour	  at	  60°C	  in	  100	  ul	  of	  50	  mM	  NaOH.	  Bound	  iron	  was	  released	  using	  freshly	  prepared	  acidic	  potassium	  permanganate	  at	  60°C	  for	  two	  hours.	  Total	  iron	  was	   detected	   using	   the	   iron-­‐detection	   reagent	   as	   described,	   transferring	   the	  assay	   to	   a	   clear	  96-­‐well	  plate	   and	   reading	   the	  absorbance	  of	   each	  well	   at	  550	  nm	  using	  a	  Synergy2	  plate	   reader	   (Biotek,	  Winooski,	  VT)	  30	  minutes	  after	  adding	   the	  detection	   reagent.	   For	   experiments	  with	  de-­‐yolked	  embryos,	   the	  protocol	  was	   the	  same	   except	   that	   each	   embryo	   was	   manually	   de-­‐yolked	   using	   fine	   forceps	  immediately	  before	  NaOH	  lysis.	  
3.3.10.	  in	  situ	  whole	  mount	  TUNEL	  assay	  After	   an	   8	   h	   infection	   with	   wild	   type	   PA14,	   Cftr	   morphant	   and	   control	  embryos	  were	  fixed	  overnight	  in	  4%	  paraformaldehyde	  in	  PBS	  at	  4°C.	  After	  fixation,	  embryos	  were	  transferred	  through	  a	  methanol	  gradient	  and	  stored	  at	  -­‐20°C	  in	  100%	  methanol	   until	   TUNEL	   assays	   were	   performed.	   Measurements	   of	   apoptosis	   were	  achieved	  using	  the	  Click-­‐it	  TUNEL	  Alexa	  Fluor	  594	  Assay	  Kit	  (Invitrogen,	  Carlsbad,	  CA)	  with	   slight	  modification.	   In	   brief,	   the	   TdT	   reaction	  was	   extended	   to	   2	   hours,	  blocking	   steps	  were	   extended	   to	   40	  minutes	   and	   the	   recommended	  BSA	   blocking	  buffer	  was	  substituted	  with	  Roche	  Western	  Blocking	  buffer	  (Roche	  1921673,	  Roche,	  Nutley,	  NJ)	  as	  previously	  described	  (13).	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3.4.	  Results	  	  
3.4.1.	  Identification	  of	  transposon	  insertion	  sites	  in	  PA14	  
mutants	  from	  the	  mariner	  transposon	  library.	  
	   PA14	  Mariner	   transposon	  mutants,	   a	   gift	   from	  Dr.	   George	  A.	  O’Toole,	  were	  characterized	  as	  described	  in	  the	  methods.	  Transposon	  insertion	  was	  confirmed	  by	  a	  2	  step	  PCR	  reaction	  and	  insertion	  of	  the	  transposon	  was	  confirmed	  in	  all	  but	  3	  of	  the	  genes	  selected	  for	  this	  study	  (Table	  3.1.).	  The	  transposon	  was	  not	  identified	  in	  3	  of	  the	  mutants	  and	  this	  was	  confirmed	  by	  amplifying	  and	  sequencing	  the	  entire	  ORF.	  The	  3	  mutants	  which	  did	  not	  appear	  to	  contain	  the	  transposon	  in	  the	  correct	  gene	  were	  not	  used	  for	  the	  remainder	  of	  the	  study.	  	  	  
Table	  3.1.	  Mariner	  transposon	  mutants	  used	  for	  this	  study.	  
Gene Product	   ORF	   Tn	   
aprA Alkaline	  Mettaloprotease	   PA14_48060	   N	   
lasA Serine	  Protease	  LasA	   PA14_40290	   Y	   
lasB Protease	  LasB	   PA14_16250	   Y	   
hplS Type	  II	  Secretion	  apparatus	   PA14_29500	   Y	   
mvfR Multiple	  Virulence	  Factor	  
Regulator	   
PA14_51340	   Y	   
rhlA Rhamnolipid	   PA14_19100	   Y	   
phzM Pyocyanin	   PA14_09490	   Y	   
toxA Exotoxin	  A	   PA14_49560	   Y	   
pvdD Pyoverdine	   PA14_33650	   N	   




	  Figure	   3.1.	   Bacterial	   Burden	   of	   Cftr	   Morphants	   and	   Controls	  Challenged	  with	  Mutants	  of	  P.	  aeruginosa.	  (a)Bacterial	  burden	  assays	  were	  performed	  as	  described	  using	   seven	  P.	  aeruginosa	  mutants.	  All	  but	   one	   showed	   a	   statistically	   significantly	   higher	   burden	   in	   Cftr	  morphant	   compared	   to	   control	   embryos.(b)	   Challenge	   with	   the	   P.	  
aeruginosa	  Exotoxin	  A	  mutant	  PA14	  ΩToxA	  resulted	  in	  similar	  burden	  levels	   in	   control	   and	   Cftr	   morphant	   embryos.	   Results	   are	  representative	   of	   three	   independent	   experiments.	   	   Error	   bars	  represent	   standard	   errors	   of	   the	   mean,	   statistical	   significance	  determined	  by	  Student’s	  t-­‐test.	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3.4.2.	  Reduced	  bacterial	  clearance	  in	  Cftr	  morphants	  is	  ablated	  
when	  challenged	  with	  a	  PA14	  ToxA	  mutant.	  Our	   previous	   study	   demonstrated	   that	   Cftr	   morphant	   embryos	   have	   a	  reduced	  ability	   to	  clear	  P.	  aeruginosa	   infection	  compared	  to	  control	  embryos.	  This	  clearance	  defect	  was	  found	  to	  be	  a	  result	  of	   factors	  regulated	  by	  the	  LasR	  quorum	  sensing	   system	   of	   this	   bacterium.	   Cftr	   morphant	   embryos	   challenged	   with	   PA14	  transposon	  insertion	  mutants	  of	  lasA,	  lasB,	  hplS,	  mvfR,	  rhlA	  and	  phzM	  were	  found	  to	  have	   significantly	   higher	   bacterial	   burdens	   than	   control	   embryos	   infected	   with	  those	  mutants.	  Upon	   infection	  with	  PA14	  ΩToxA,	   a	  mutant	  which	   cannot	  produce	  Exotoxin	   A,	   bacterial	   burden	   in	   the	   Cftr	   morphants	   was	   similar	   to	   that	   of	   the	  controls	  (Figure	  3.1.a	  )	  and	  the	  number	  of	  bacteria	  recovered	  at	  8	  hpi	  was	  consistent	  with	  that	  of	  wild	  type	  PA14,	  approximately	  2	  x	  103	  CFU/ml	  (Figure	  3.1.b).	  
3.4.3.	  Neutrophil	  migration	  in	  Cftr	  morphants	  is	  restored	  upon	  
infection	  with	  a	  PA14	  ToxA	  mutant.	  An	  unexpected	  result	  from	  our	  previous	  study	  was	  the	  finding	  that	  directed	  chemotaxis	   of	   neutrophils	   to	   a	   localized	   infection	   with	   P.	   aeruginosa	   was	  dramatically	  reduced	  in	  the	  Cftr	  morphant	  embryos.	  Because	  the	  bacterial	  clearance	  defect	  in	  the	  Cftr	  morphants	  was	  restored	  when	  embryos	  were	  challenged	  with	  an	  ETA	  mutant	  of	  PA14,	  and	  ETA	  has	  previously	  been	  implicated	  in	  altering	  leukocyte	  activity	  and	  function	  (76,	  108),	  we	  next	  examined	  neutrophil	  migration	  to	  the	  PA14	  ETA	  mutant.	   	  At	  48	  hpf,	  50	  CFUs	  of	  PA14	  ΩToxA	  were	   injected	   into	   the	  hindbrain	  ventricle	  (HBV),	  as	  described	  previously,	  of	  morphant	  and	  control	  Tg(mpx:GFP)i114	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transgenic	  embryos.	  Neutrophils	  in	  the	  HBV	  were	  enumerated	  at	  180	  minutes	  post	  infection	  (mpi)	  (Figure	  3.2).	  The	  average	  number	  of	  neutrophils	   in	  the	  HBV	  of	  Cftr	  morphants	  was	  found	  to	  be	  the	  same	  as	  in	  infected	  controls	  (15	  cells),	  and	  similar	  to	  the	  number	  shown	  previously	  in	  control	  fish	  infected	  with	  WT	  PA14.	  The	  reduction	  in	  migration	  behavior	  of	  neutrophils	  in	  response	  to	  a	  P.	  aeruginosa	  infection	  appears	  to	  be	  a	  result	  of	  ETA	  production	  by	  the	  bacterium.	  




	  Figure	   3.3.	   Cftr	   Morphant	   Zebrafish	   Embryos	   Display	   an	   Iron	  Deficiency.	   Total	   iron	   per	   embryo,	   represented	   and	   nano-­‐moles	   per	  embryo,	   in	  whole	  (a)	  and	  de-­‐yolked	  (b)	  zebrafish	  embryos	  at	  48	  hpf.	  No	   significant	  difference	  was	   found	   in	  whole	   fish	  measurements	  but	  significantly	   less	   iron	  was	   found	   in	   the	   bodies	   of	   the	   Cftr	  morphant	  fish	   after	   removal	   of	   the	   yolk.	  Results	   are	   shown	  as	   the	  pooled	  data	  from	  three	  independent	  experiments.	   	  Error	  bars	  represent	  standard	  errors	   of	   the	   mean,	   statistical	   significance	   was	   determined	   by	   the	  Student’s	  t-­‐test.	  
	  
3.4.4.	  Iron	  status	  of	  Cftr	  morphant	  zebrafish	  embryos.	  Iron	   deficiency	   is	   common	   among	   CF	   patients	   and	   is	   thought	   to	   be	   a	  consequence	  of	  chronic	  inflammation	  in	  response	  to	  respiratory	  tract	  infections	  and	  poor	  dietary	  uptake	  of	  iron	  resulting	  from	  poor	  pancreatic	  function.	  To	  test	  the	  iron	  status	  of	  the	  Cftr	  morphant	  zebrafish	  embryos,	  a	  colorimetric	  Ferrozine	  based	  assay	  was	  employed.	  The	  total	  amount	  of	  iron	  was	  found	  to	  be	  about	  16	  nmols	  per	  embryo	  and	  was	  similar	   in	  Cftr	  morphant	  and	  control	  embryos	  (Figure	  3.3.a).	  Because	   the	  embryos	   are	   completely	   reliant	   on	   their	   yolk	   for	   nutrients	   at	   48	   hpf,	   and	   the	  morphant	  and	  control	  fish	  were	  both	  spawned	  from	  the	  same	  wild	  type	  parents,	  we	  next	  sought	  to	  measure	  the	  ability	  of	  the	  embryo	  to	  take	  up	  iron	  from	  its	  yolk.	  The	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assay	   was	   performed	   on	   embryos	   that	   had	   been	   manually	   de-­‐yolked	   using	   fine	  forceps	  and	  Cftr	  morphant	  embryos	  were	  found	  to	  have	  taken	  up	  significantly	  less	  iron	   from	   their	   yolk	   (7.9	   ±0.15	   nmols)	   than	   control	   embryos	   (10.26±0.24	   nmols)	  (Figure	  3.3.b).	  
3.4.5.	  ETA	  induced	  apoptosis	  in	  Cftr	  Morphant	  embryos.	  ETA	  of	  P.	  aeruginosa	  has	  been	  found	  to	  induce	  apoptosis	  by	  inhibiting	  protein	  synthesis	  of	  eukaryotic	  cells.	  To	  test	  whether	  it	  was	  possible	  to	  visualize	  this	  effect	  
in	  vivo,	  control	  and	  Cftr	  morphant	  zebrafish	  embryos	  were	  injected	  with	  50	  CFUs	  of	  wild	  type	  PA14	  at	  48	  hpf	  as	  described	  previously.	  At	  8	  hpi,	  embryos	  were	  fixed	  with	  4%	  paraformaldehyde	  and	  a	  whole	  mount	   in	  situ	   fluorescence	  based	  TUNEL	  assay	  was	   performed	   as	   described	   in	   methods.	   A	   disseminated	   infection	   with	   a	   small	  inoculum	  does	  not	  appear	  to	  result	  in	  a	  significant	  amount	  of	  measurable	  cell	  death	  at	   this	   early	   time	   point	   in	   either	   Cftr	   morphant	   or	   control	   embryos	   (data	   not	  shown).	  	  	  	  	  
3.5.	  Discussion	  	  Our	   previous	   study	   established	   the	   zebrafish	   embryo	   as	   a	   viable	   model	  organism	   for	   the	   study	   of	   in	   vivo	   host–pathogen	   response	   in	   the	   context	   of	   cystic	  fibrosis	   (104).	   Using	   morpholino	   antisense	   oligonucleotides	   targeted	   at	   the	  zebrafish	  CFTR	  ortholog,	  we	  were	  able	  to	  effectively	  knock	  down	  the	  expression	  of	  zebrafish	  Cftr	  and	  use	  these	  Cftr	  morphant	  zebrafish	  to	  study	  the	  dynamics	  of	  early	  innate	  immune	  responses	  to	  acute	  bacterial	  infections.	  We	  found	  that	  Cftr	  morphant	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embryos	  exhibited	  a	  dampened	  overall	   immune	  response	  characterized	   in	  part	  by	  reduced	  production	  of	  reactive	  oxygen	  species	  (ROS)	  and	  a	  reduction	  in	  the	  directed	  chemotaxis	   of	   zebrafish	   neutrophils	   to	   a	   P.	   aeruginosa	   infection.	   We	   further	  demonstrated	   that	   Cftr	   morphant	   embryos	   had	   a	   reduced	   ability	   to	   clear	   acute	  infections	   caused	   by	   P.	   aeruginosa,	   and	   not	   by	   other	   respiratory	   pathogens	  commonly	   isolated	   from	   CF	   patients.	   This	   reduction	   in	   bacterial	   clearance	   was	  determined	   to	   be	   a	   result	   of	   the	   LasR	   quorum	   sensing	   (QS)	   system,	   and	   the	  downstream	  virulence	  factors	  that	  are	  regulated	  through	  LasR.	  	  Numerous	  virulence	  factors	  are	  transcriptionally	  regulated	  by	  LasR	  QS	  (102).	  It	  was	  the	  goal	  of	  this	  study	  to	  attempt	  to	  identify	  which	  of	  these	  virulence	  factors	  are	  particularly	  important	  early	  in	  the	  course	  of	  acute	  P.	  aeruginosa	  infections	  in	  our	  Cftr	   morphant	   zebrafish	   embryos.	   P.	   aeruginosa	   strain	   PA14	   mutants	   from	   the	  mariner	  transposon	  mutant	  library	  (73)	  were	  selected	  based	  on	  previous	  reports	  of	  genes	  that	  are	  transcriptionally	  controlled	  or	  otherwise	  regulated	  by	  LasR	  and	  RhlR	  (102).	   The	   earliest	   described	   transcriptional	   regulation	   by	   LasR	   and	  RhlR,	   indeed	  the	  genes	  they	  were	  named	  after,	  are	  the	  elastases	  LasA	  and	  LasB	  and	  rhamnolipid,	  a	  biosurfactant	   essential	   for	  biofilm	  growth	   in	  P.	   aeruginosa(96,	  144).	   Infection	  of	  Cftr	  morphant	  zebrafish	  embryos	  with	  mutants	  of	  either	  LasA,	  LasB	  or	  RhlA	  resulted	  in	   a	   significantly	   higher	   bacterial	   burden	   after	   8	   h	   of	   infection	   than	   what	   was	  observed	  in	  control	  embryos.	  The	  difference	  in	  bacterial	  burden	  in	  Cftr	  morphants	  compared	  to	  controls	  was	  significantly	  smaller	  than	  what	  was	  previously	  observed	  with	   wild	   type	   PA14,	   indicating	   that	   virulence	   in	   this	   model	   is	   impacted	   when	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expression	  of	  these	  genes	  is	  lost,	  but	  that	  these	  genes	  are	  not	  solely	  responsible	  for	  the	   reduced	   bacterial	   clearance.	   LasR	   QS	   system	   also	   controls	   the	   expression	   of	  components	  of	   the	  Type	   II	   general	   secretion	  pathway	  of	  P.	  aeruginosa.	   To	   test	   for	  the	  involvement	  of	  this	  pathway,	  we	  selected	  an	  hplS	  mutant.	  Infection	  with	  a	  PA14	  HplS	  mutant	   resulted	   in	   the	   same	   reduction	   in	   bacterial	   clearance	   observed	  with	  wild	   type	   PA14.	   The	   redox	   active	   blue-­‐green	   pigment	   pyocyanin	   that	   is	   produced	  during	   P.	   aeruginosa	   growth	   and	   is	   indicative	   of	   P.	   aeruginosa	   infections	   in	  most	  clinical	  settings	  was	  tested	  for	   its	  role	   in	  virulence	   in	  our	  Cftr	  morphant	  zebrafish.	  Although	   pyocyanin	   is	   regulated	   by	   LasR,	   it	   is	   also	   regulated	   through	   another	   QS	  system,	   the	   Multiple	   Virulence	   Factor	   Regulator	   (mvfR),	   which	   controls	   the	  expression	   of	   pyocyanin,	   hydrogen	   cyanide	   and	   others	   (29).	   	   Infection	  with	   PA14	  mutants	   of	   either	   phzM,	   an	   enzyme	   essential	   for	   the	   production	   of	   pyocyanin,	   or	  with	  a	  mutant	  of	  mvfR,	  QS	  controlled	  regulator	  of	  pyocyanin	  production,	  yielded	  the	  same	  reduced	  bacterial	  clearance	  observed	  during	   infections	  with	  wild	   type	  PA14,	  indicating	  that	  pyocyanin	  and	  other	  genes	  under	  control	  of	  MvfR	  are	  not	  responsible	  for	  the	  bacterial	  clearance	  defect	  in	  the	  Cftr	  morphants.	  	  Among	  the	  PA14	  mutants	  examined	  in	  this	  study,	  only	  infection	  with	  a	  PA14	  ToxA	  mutant,	  a	  mutant	  that	  cannot	  express	  Exotoxin	  A	  (ETA),	  resulted	  in	  bacterial	  clearance	  by	  Cftr	  mophant	   embryos	   that	  was	  equal	   to	   that	  of	   controls.	  While	  ETA	  expression	   is	   not	   under	   the	   control	   of	   LasR	   per	   se,	   LasR	   QS	   has	   been	   shown	   to	  enhance	  the	  expression	  of	  this	  toxin	  (44).	  The	  iron-­‐starvation	  sigma	  factor	  PvdS	  is	  responsible	   for	   the	   regulation	   of	   ETA	   and	   pyoverdine	   in	   P.	   aeruginosa,	   and	   the	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expression	  of	  these	  genes	  is	  dramatically	  up-­‐regulated	  during	  growth	  in	  iron-­‐limited	  environments.	   ETA	   is	   a	   powerful	   and	   lethal	   toxin	   and	   has	   been	   recovered	   from	  sputum	  of	  CF	  patients	  chronically	   infected	  with	  P.	  aeruginosa	  (59).	  The	  expression	  of	  ETA	  was	  also	  shown	   to	  strongly	  correlate	  with	  expression	   levels	  of	  LasR	   in	   the	  lungs	   these	  patients	   (138).	  By	  ADP-­‐ribosylating	   elongation	   factor	  2	   and	   inhibiting	  protein	   synthesis,	   ETA	   effectively	   induces	   the	   death	   of	   any	   eukaryotic	   cells	   that	  encounter	  this	  toxin	  (56).	  	  ETA	  has	  been	  shown	  in	  both	  mouse	  and	  dog	  models	  to	  dramatically	  reduce	  the	   number	   of	   circulating	   leukocytes	   following	   ip	   or	   iv	   injection	   (76)	   and	  cytotoxicity	   has	   been	   demonstrated	   using	   isolated	   human	   macrophages	   (108).	  Pollack	  and	  Anderson	  also	  noted	  a	  significant	  reduction	  in	  the	  phagocytic	  ability	  of	  these	   isolated	   human	   macrophages	   following	   a	   sub-­‐lethal	   dose	   of	   ETA	   (108).	   To	  determine	   if	   ETA	   may	   be	   the	   cause	   of	   the	   reduced	   neutrophil	   migration	   to	   a	   P.	  
aeruginosa	  infection	  in	  the	  hindbrain	  ventricle	  (HBV)	  of	  Cftr	  morphant	  zebrafish,	  we	  repeated	   the	  assay	  with	   the	  PA14	  ToxA	  mutant.	  Neutrophil	  migration	   to	   infection	  with	   the	   ETA	  mutant	   in	   Cftr	  morphant	   embryos	  was	   restored	   to	   levels	   similar	   to	  control	  embryos	  and	  the	  numbers	  of	  neutrophils	  were	  consistent	  with	  previous	  data	  using	  wild	   type	  PA14	   in	   control	   embryos.	  This	   indicates	   that	  ToxA	  may	   in	   fact	  be	  responsible	   for	   the	   reduced	   ability	   of	   Cftr	   morphant	   embryos	   to	   clear	   an	   acute	  infection	   with	   P.	   aeruginosa.	   The	   finding	   that	   bacterial	   clearance	   and	   directed	  neutrophil	  chemotaxis	  were	  restored	  in	  our	  Cftr	  morphant	  embryos	  when	  infected	  with	   a	   ToxA	  mutant	  was	   unanticipated	   because	   previous	   studies	   by	  Woods,	   et	   al.	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(158),	   and	   Blackwood,	   et	   al.	   (4),	   demonstrated	   that	   in	   rats	   and	   guinea	   pigs,	   ETA	  played	  a	  major	  role	  in	  virulence	  during	  chronic,	  but	  not	  acute	  lung	  infections.	  This	  data	  is	  not	  in	  contradiction	  to	  these	  previous	  reports,	   in	  fact	  we	  saw	  no	  significant	  difference	   in	   the	   infection	   of	   control	   embryos	   infected	   with	   wild	   type	   PA14	   or	  PA14ΩToxA.	  This	  may	  be	  the	   first	  report	   that	   implicates	  ETA	  as	  a	  major	  virulence	  factor	  in	  acute	  infections	  by	  P.	  aeruginosa	  in	  the	  context	  of	  CF.	  While	  the	  expression	  of	  this	  toxin	  has	  been	  confirmed	  in	  CF	  clinical	  isolates	  of	  P.	  aeruginosa	  and	  the	  toxin	  has	   been	   directly	   detected	   in	   sputum	   of	   chronically	   infected	   patients,	   we	   were	  unable	   to	   find	   any	   reports	   of	   the	   importance	   of	   ETA	   in	   the	   initial	   stages	   of	   P.	  
aeruginosa	  infection	  of	  the	  CF	  lung.	  	  ETA	  is	  not	  the	  only	  toxin	  produced	  by	  P.	  aeruginosa.	  Indeed,	  ETA	  is	  not	  even	  the	  only	  ADP-­‐ribosylase	  that	  is	  expressed	  by	  P.	  aeruginosa	  (141).	  Exoenzyme	  S	  has	  also	  been	  described	  as	  an	  ADP-­‐ribosylase	  and	  pathogenicity	  during	  acute	  infection	  of	   a	  neonatal	  mouse	   lung	  was	  not	   reduced	  by	   a	  P.	   aeruginosa	  mutant	  defective	   in	  Exo-­‐S	   expression	   (141).	   Despite	   the	   obvious	   effects	   ETA	   has	   on	   neutrophil	  migration	   in	   response	   to	   an	   infection,	   and	   the	   reduced	   bacterial	   clearance	   that	  seems	  to	  be	  a	  result	  of	  this	  defect,	  we	  sought	  to	  identify	  a	  possible	  link	  between	  ETA	  and	   CF	   in	   humans	   that	   has	   not	   yet	   been	   described.	   It	   is	   well	   known	   that	   ETA	  expression	   is	   highly	   up-­‐regulated	   during	   the	   iron-­‐starvation	   response	   of	   the	  bacterium	  (43).	  The	  iron	  status	  of	  CF	  patients	  has	  been	  a	  matter	  of	  great	  debate	  over	  the	  past	  decade.	  A	  multitude	  of	   clinical	   reports	  exist	   showing	   that	  anywhere	   from	  30–70%	   of	   CF	   patients	   are	   iron	   deficient	   (ID)	   and	   a	   large	   proportion	   of	   these	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patients	  suffer	   from	  anemia	   linked	  to	  this	  ID	  (1,	  34,	  41,	  64,	  109,	  121,	  153).	  Recent	  studies,	  however,	  have	  identified	  extremely	  high	  levels	  of	  iron	  in	  the	  sputum	  of	  CF	  patients	  compared	  to	  iron	  levels	  in	  healthy	  people	  (118,	  120,	  136,	  137).	  There	  is	  a	  great	   deal	   of	   controversy	   over	   whether	   these	   findings	   are	   indicative	   of	  complications	   of	   defective	   expression	   of	   CFTR	   or	   whether	   they	   are	   a	   product	   of	  chronic	  persistent	  bacterial	  infections	  and	  the	  resultant	  hyper-­‐inflammation.	  Recent	  studies	  have	  revealed	  that	  the	  increased	  iron	  in	  the	  sputum	  is	  caused	  by	  higher	  than	  normal	   iron	   secretion	  by	  CF	   epithelial	   cells,	   prompting	   them	   to	  begin	   testing	   iron	  chelation	  therapy	  to	  attempt	  to	  remove	  the	  chronic	  P.	  aeruginosa	  infections	  in	  these	  patients	   (46,	  88,	  89).	   Interestingly,	   the	   same	  group	  has	   recently	   reported	   that	   the	  iron	   in	   CF	   sputum	   strongly	   correlated	   with	   their	   clinical	   condition	   and	   infection	  status,	   and	   they	   failed	   to	   correlate	   sputum	   iron	   concentrations	   with	   serum	   iron	  levels,	  indicating	  that	  the	  iron	  loss	  through	  airway	  inflammation	  is	  not	  as	  significant	  as	  once	  believed	  (46,	  121).	  Our	   findings	   regarding	   ETA	   and	   the	   clinical	   data	   available	   regarding	   iron	  deficiency	   of	   CF	   patients	   prompted	   us	   to	   investigate	   if	   the	   iron	   status	   of	   our	   Cftr	  morphant	  zebrafish	  was	  measurable	  and	   if	   it	  was	  altered	  compared	   to	   the	  control	  embryos.	  Because	  the	  zebrafish	  embryo	  is	  reliant	  on	  its	  yolk	  for	  nutrients	  at	  48	  hpf,	  and	  the	  morphant	  embryos	  were	  spawned	  from	  the	  same	  wild	  type	  parents	  as	  the	  control	  embryos,	  we	  found	  that	  the	  total	  amount	  of	   iron	  in	  the	  whole	  embryo	  was	  about	  16	  nmols	  per	   fish.	  Upon	  removal	  of	   the	  remainder	  of	   the	  yolk	  at	  48	  hpf,	  we	  found	  that	  the	  Cftr	  morphant	  embryos	  had	  taken	  up	  significantly	  less	  iron	  from	  their	  
	  	  
	  78	  















DISCUSSION	  AND	  FUTURE	  DIRECTIONS	  
	  Researchers	   have	   been	   struggling	   for	   decades	   to	   elucidate	   the	   molecular	  mechanisms	   that	  make	   cystic	   fibrosis	   (CF)	  patients	   susceptible	   to	   infection	  by	   the	  opportunistic	   pathogen	   P.	   aeruginosa,	   a	   pathogen	   that	   rarely	   causes	   infection	   in	  healthy	  individuals	  (80).	  Many	  advances	  have	  been	  made	  in	  the	  characterization	  of	  the	  unique	  pathophysiology	  of	   the	  CF	  condition	   in	  humans,	  but	   these	  studies	  have	  fallen	   short	   of	   determining	   the	   specifics	   of	   the	   relationship	   between	   this	  environmental	  microbe	  and	  the	  chloride	  channel	  CFTR	  in	   the	   lungs	  of	  CF	  patients.	  Researchers	   have	   been	   at	   a	   disadvantage	   in	   these	   studies	   because	   of	   a	   lack	   of	   a	  suitable	  animal	  model.	  Much	  has	  been	  learned	  in	  recent	  years	  about	  the	  growth	  and	  adaptation	  of	  this	  bacterium	  to	  the	  conditions	  in	  the	  CF	  lung	  through	  the	  use	  of	  cell	  culture	   models,	   using	   both	   primary	   and	   immortalized	   epithelial	   cell	   lines,	   or	  through	  studies	  in	  murine	  models.	  Although	  CF	  researchers	  have	  developed	  nearly	  a	  dozen	  CF	  mouse	  models	  with	  varying	  mutations	  in	  the	  CFTR	  gene,	  researchers	  must	  select	   the	   appropriate	   mouse	   for	   their	   work	   because	   none	   of	   these	   models	   have	  successfully	   replicated	   the	   wide	   array	   of	   symptoms	   that	   are	   caused	   by	   defective	  CFTR	   in	   humans.	   At	   the	   most	   basic	   level,	   the	   mouse	   models	   fail	   to	   be	   useful	   in	  infection	   studies	   because	   CFTR	   knockout	   mice	   fail	   to	   spontaneously	   develop	   P.	  
aeruginosa	   infections,	   as	   humans	   do,	   and	   it	   is	   especially	   difficult	   to	   artificially	  establish	   a	   P.	   aeruginosa	   infection	   in	   these	   models,	   particularly	   acute	   infections,	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because	  mice	   have	  mechanisms	   in	   place	   that	   protect	   them	   from	   these	   challenges	  that	  are	  found	  in	  human	  airways.	  	  We	  have	  proposed	  the	  use	  of	   the	  zebrafish	  embryo	  as	  a	  model	   for	  studying	  the	   innate	   immune	  response	   to	  acute	   infections	  with	  P.	  aeruginosa.	  A	  criticism	  we	  commonly	  receive	  when	  presenting	  our	  work	  is	  that	  the	  damage	  that	  is	  caused	  by	  P.	  
aeruginosa	   in	   the	   CF	   lung	   is	   a	   result	   of	   chronic	   persistent	   infections,	   not	   acute	  infections.	   While	   we	   do	   not	   disagree	   with	   researchers	   attempting	   to	   develop	  strategies	  to	  combat	  chronic	  P.	  aeruginosa	  infections	  that	  are	  particularly	  difficult	  to	  treat,	   we	   argue	   that	   every	   chronic	   bacterial	   infection	   that	   has	   been	   established	  begins	   first	   as	   an	   acute	   infection,	   and	   that	   it	   is	   the	   responsibility	   of	   the	   innate	  immune	  system	  to	  combat	  these	  acute	  infections	  and	  rapidly	  eradicate	  them	  before	  the	  condition	  worsens.	  Although	  our	  model	  suffers	  the	  disadvantage	  of	  not	  having	  a	  structure	   homologous	   to	   the	   human	   airway,	   we	   have	   been	   able	   to	   identify	  many	  important	  factors	  contributing	  to	  susceptibility	  to	  infection	  that	  are	  impacted	  by	  the	  loss	  of	  Cftr	  expression.	  	  In	   chapter	   2,	   we	   discuss	   the	   finding	   that	   loss	   of	   Cftr	   perturbs	   the	   innate	  immune	   response	   in	   the	   zebrafish	   embryo,	   characterized	   in	   part	   by	   the	   reduced	  ability	   of	   the	   Cftr	   morphant	   zebrafish	   to	   produce	   reactive	   oxygen	   species,	   an	  essential	   element	   of	   bacterial	   killing	   by	   neutrophils.	  We	   also	   identified	   a	   reduced	  neutrophil	  migration	  response	  in	  the	  neutrophils	  of	  Cftr	  morphant	  fish	  to	  infection	  by	  P.	  aeruginosa.	  Taken	  together,	  these	  data	  indicate	  that	  loss	  of	  Cftr	  may	  make	  the	  zebrafish	  embryos	  more	  susceptible	  to	  bacterial	  infection.	  The	  pivotal	  finding	  of	  this	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initial	   report	   was	   that	   Cftr	   morphant	   embryos	   had	   a	   reduced	   ability	   to	   clear	  infection	   by	   P.	   aeruginosa.	   We	   further	   addressed	   the	   notion	   of	   susceptibility	   to	  bacterial	  infection	  in	  general	  by	  challenging	  the	  Cftr	  morphant	  embryos	  with	  other	  bacterial	  species	  commonly	  implicated	  in	  respiratory	  infections	  in	  CF.	  We	  found	  that	  the	  bacterial	  clearance	  defect	  of	  the	  Cftr	  morphants	  was	  unique	  to	  P.	  aeruginosa	  and	  subsequently	  identified	  the	  LasR	  quorum	  sensing	  (QS)	  system	  of	  P.	  aeruginosa,	  and	  the	   virulence	   factors	   that	   are	   expressed	   through	   it,	   as	   being	   responsible	   for	   this	  reduced	  ability	  to	  clear	  the	  infection.	  In	  chapter	  3,	  we	  attempted	  to	  examine	  each	  of	  the	  virulence	  factors	  that	  are	  regulated	   by	   LasR	   in	   P.	   aeruginosa	   in	   order	   to	   identify	   which	   of	   these	   systems	  contribute	   to	   pathogenesis	   in	   the	   zebrafish	   embryos.	   We	   performed	   infection	  studies	   using	   several	   P.	   aeruginosa	  mutants	   from	   the	  mariner	   transposon	   library	  developed	   by	   Liberati,	   et	   al.	   (73)	   and	   compared	   bacterial	   burdens	   in	   the	   Cftr	  morphant	   and	   control	   zebrafish.	   We	   found	   that	   infection	   with	   four	   of	   the	   P.	  
aeruginosa	  mutants	  studied	  resulted	  in	  a	  reduction	  in	  the	  bacterial	  clearance	  defect	  observed	   in	   the	   Cftr	   morphant	   embryos,	   and	   infection	   by	   one	   of	   these	   mutants	  resulted	   in	  bacterial	  burdens	   that	  were	   identical	   in	   the	  Cftr	  morphant	  and	  control	  embryos.	   When	   challenged	   with	   a	   P.	   aeruginosa	   mutant	   that	   cannot	   produce	  Exotoxin	   A	   (ETA),	   a	   potent	   and	   lethal	   toxin	   secreted	   by	   the	   bacterium	   during	  infection	   and	   as	   a	   result	   of	   the	   iron	   starvation	   response,	   Cftr	  morphant	   zebrafish	  embryos	  were	  able	  to	  clear	  the	  infection	  as	  efficiently	  as	  the	  control	  embryos	  were,	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implicating	   ETA	   as	   a	   crucial	   component	   in	   the	   susceptibility	   of	   CF	   patients	   to	  infection	  by	  P.	  aeruginosa.	  Although	  the	  mechanism	  of	  toxicity	  of	  ETA	  has	  been	  well	  described,	  and	  the	  toxin	  is	  routinely	  identified	  in	  the	  sputum	  of	  CF	  patients	  infected	  with	  P.	  aeruginosa,	  the	  contributions	  of	  this	  toxin	  to	  the	  initial	  stages	  of	  infection	  and	  colonization	  of	  the	  CF	   lung	   by	   P.	   aeruginosa	   have	   not	   been	   previously	   identified.	   In	   fact,	   a	   previous	  study	  had	  ruled	  out	  the	  significance	  of	  ETA	  during	  acute	  respiratory	  tract	  infections	  in	  a	  guinea	  pig	  model,	   seemingly	   in	  contradiction	   to	  our	  hypothesis.	   Indeed,	  while	  ETA	  is	  not	  important	  during	  acute	  infections	  of	  normal	  animals,	  reports	  of	  infection	  studies	  with	  ETA	  in	  a	  CF	  model	  do	  not	  exist.	  Thus,	  we	  are	  the	  first	  to	  report	  that	  ETA	  is	  a	  critical	  component	   in	  suppressing	   the	   immune	  response	  of	   the	  host	  during	  an	  acute	  infection	  using	  an	  animal	  model	  of	  CF.	  When	  challenged	  with	  the	  ETA	  mutant	  of	  P.	   aeruginosa,	   we	   found	   that	   the	   ability	   of	   Cftr	  morphant	   embryos	   to	   clear	   the	  infection	  was	  restored	  to	  the	   level	  of	   the	  control	  embryos,	  and	  that	   the	  neutrophil	  migration	   response	   in	   the	   morphants	   was	   as	   robust	   in	   the	   morphants	   as	   in	   the	  controls.	  	  The	  ablation	  of	  the	  neutrophil	  migration	  defect	  in	  the	  Cftr	  morphants	  may	  in	  fact	   result	   in	   the	   restoration	   of	   bacterial	   clearance,	   indicating	   that	   the	   slowed	  response	  of	  Cftr	  morphant	  neutrophils	  to	  P.	  aeruginosa	  may	  actually	  be	  a	  result	  of	  exposure	  to	  the	  bacterial	  toxin.	  This	  effect	  has	  been	  previously	  described	  in	  mouse	  and	  dog	  models,	  where	  direct	  injection	  of	  the	  purified	  toxin	  resulted	  in	  a	  reduction	  in	  the	  number	  of	  circulating	  leukocytes	  and	  toxic	  shock	  in	  these	  animals	  (76).	  ETA	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has	  also	  been	  shown	  to	  induce	  apoptosis	  in	  human	  macrophages	  and	  directly	  inhibit	  phagocytosis	   by	   these	   cells	   (108).	   Previous	  work	   has	   demonstrated	   that	   ETA	   has	  little	  effect	  on	  phagocytosis	  and	  bacterial	  killing	  by	  neutrophils	  in	  rabbits	  (100),	  but	  no	  studies	  could	  be	  found	  examining	  inhibition	  of	  neutrophil	  migration	  by	  ETA.	  Our	  studies	  of	   the	   responses	  of	   zebrafish	  phagocytes	  have	  been	   limited	   to	  neutrophils	  because	  a	  true	  macrophage	  specific	  transgenic	  line	  has	  not	  been	  available.	  Recently,	  a	   transgenic	   line	   of	   zebrafish,	   which	   express	   a	   fluorescent	   protein	   driven	   by	   the	  macrophage	  specific	  mpeg1	  promoter,	  has	  been	  described	  (36).	  Because	  ETA	  has	  a	  more	   dramatic	   effect	   on	   normal	   macrophages	   from	   humans	   and	   other	   animals,	  future	   studies	   of	  migration	   and	   phagocytosis	   responses	  may	   prove	   to	   be	   another	  critical	  component	  of	  bacterial	  clearance	  that	  is	  altered	  in	  our	  zebrafish	  CF	  model.	  The	   inhibition	   of	   neutrophil	   and	   possibly	   macrophage	   recruitment	   and	  killing	   in	   the	   Cftr	  morphant	   zebrafish	   by	   P.	   aeruginosa	   ETA	   identifies	   a	   potential	  mechanism	   by	  which	   the	   bacterium	   evades	   the	   immune	   responses	   of	   the	   host	   in	  order	   to	   establish	   an	   infection	   in	   the	   CF	   lung.	   The	   next	   question	   we	   wanted	   to	  address	  was	  why	   ETA	  was	   significant	   during	   these	   infections.	   ETA	   is	   only	   one	   of	  many	   virulence	   factors	   expressed	   by	   P.	   aeruginosa	   during	   infections,	   and	   indeed,	  only	  one	  of	   the	   toxins	  with	  ADP-­‐ribosylase	  activity.	  Exoenzyme	  S	   (ExoS)	  has	  been	  shown	  to	  act	   in	  the	  same	  manner	  and	  target	  the	  same	  eukaryotic	  cell	  processes	  as	  ETA.	  One	  of	   the	  major	   findings	   from	  our	   initial	   report	  described	   in	   chapter	  2	  was	  that	  the	  Type	  III	  Secretion	  System,	  the	  only	  mechanism	  by	  which	  ExoS	  is	  delivered	  to	  eykaryotic	   cells,	   is	  not	   responsible	   for	   the	   reduction	   in	  bacterial	   clearance.	  The	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action	   of	   inducing	   apoptosis	   and	   inhibiting	   phagocytosis	   and	   bacterial	   killing,	  therefore,	   is	   not	   simply	   specific	   to	   ETA,	   but	   could	   be	   an	   effect	   of	   enhanced	  expression	   of	   this	   toxin	   by	   the	   bacteria	   during	   infection	   in	   the	   Cftr	   morphant	  embryos.	  We	   next	   focused	   on	   the	   regulatory	   networks	   that	   control	   ETA,	   since	   the	  expression	   level	   of	   the	   exoenzyme	   seemed	   to	   be	   a	   plausible	   explanation	   for	   the	  importance	   of	   the	   toxin	   during	   acute	   infection	   in	   our	   Cftr	   morphants,	   but	   the	  dispensable	  nature	  of	   the	  toxin	  during	  acute	   infection	  has	  been	  described	   in	  other	  models.	   Our	   initial	   report	   identified	   genes	   regulated	   through	   the	   LasR	   pathway,	  including	  ETA,	  as	  targets	  for	  future	  study.	  While	  the	  expression	  of	  ETA	  is	  highly	  up-­‐regulated	  when	  the	  LasR	  QS	  system	  is	  activated,	  ETA	  is	  primarily	  regulated	  through	  the	   iron-­‐starvation	   sigma	   factor	   PvdS.	   When	   the	   bacterium	   is	   growing	   in	  environments	  where	   iron	   is	   limited,	   including	   inside	   hosts	   during	   infection,	   PvdS	  activates	   the	   expression	   of	   ETA	   and	   the	   siderophore	   pyoverdine	   (PVD).	   ETA	   is	  released	  into	  the	  environment	  to	  kill	  any	  eukaryotic	  cells	  that	  are	  nearby,	  releasing	  the	   iron	   they	   have	   stored.	   PVD	   expression	   increases	   and	   the	   siderophore	   is	  subsequently	  released	   to	  chelate	   the	   iron	   that	  was	  released	  by	   the	  dying	  cells	  and	  return	   it	   to	   the	   bacterium.	   This	   is	   a	   highly	   effective	   and	   elegant	   mechanism	   of	  attaining	   iron	   in	   environments	  where	   it	   is	   very	   limited.	   The	   system	   is	   also	   highly	  effective	  in	  acquiring	  iron,	  among	  other	  vital	  nutrients	  during	  pathogenesis	  in	  plant	  and	  animal	  hosts.	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The	   fact	   that	   ETA	   is	   primarily	   regulated	   by	   iron	   availability	   is,	   in	   itself,	   a	  significant	  component	  of	  the	  specificity	  of	  these	  infections.	  Iron	  deficiency	  (ID),	  and	  often	  an	  ID	  associated	  anemia	  is	  a	  common	  symptom	  of	  CF,	  observed	  in	  about	  30-­‐70%	  of	  CF	  patients	  depending	  on	  their	  age	  and	  clinical	  condition	  (1,	  34,	  41,	  64,	  109,	  121,	  153).	  We	  next	  wanted	  to	  determine	  whether	  our	  CF	  zebrafish	  model	  replicated	  the	   ID	   status	   of	   humans	  with	   CF.	   Adapting	   a	   cull	   culture	   based	   colorometric	   iron	  assay,	  we	  found	  that	  our	  Cftr	  morphant	  zebrafish	  embryos	  had	  significantly	  less	  iron	  than	  control	  embryos	  did.	  The	  difference	  in	  total	  iron	  we	  found	  was	  small,	  but	  it	  is	  an	  accurate	  measure	  of	   the	  total	   iron	  the	  fish	  were	  able	  to	  absorb	  from	  their	  yolk.	  Future	   studies	   are	   needed	   to	   elucidate	   the	   exact	   mechanisms	   by	   which	   our	   Cftr	  morphant	  zebrafish	  are	  ID.	  A	  great	  deal	  of	  controversy	  exists	  in	  clinical	  reports	  of	  ID	  in	  CF	  patients.	  The	  cause	  of	  the	  ID	  is	  generally	  attributed	  to	  (i)	  a	  reduced	  ability	  of	  the	  body	  to	  take	  up	  iron	  and	  other	  key	  nutrients	  because	  of	  deteriorating	  pancreatic	  function,	  (ii)	  a	  loss	  of	  iron	  through	  bleeding	  into	  the	  intestines,	  a	  common	  symptom	  in	   CF,	   or	   (iii)	   loss	   of	   iron	   through	   chronic	   persistent	   infections	   of	   the	   respiratory	  tract,	  and	  the	  subsequent	  inflammation	  in	  response	  (46).	  It	  may	  be	  possible	  to	  use	  the	   CF	   zebrafish	   model	   we	   have	   established	   to	   determine	   which	   of	   these	  possibilities	  are	   the	  most	  significant.	  Studies	  could	  be	  performed	  after	   infection	  to	  measure	  the	  contribution	  of	  the	  inflammation	  response	  to	  iron	  loss	  in	  the	  zebrafish.	  Iron	  measurements	   could	  be	  performed	  on	  older	   fish,	   after	   the	  yolk	   is	   completely	  absorbed,	  but	  before	  the	  fish	  begins	  actively	  feeding.	  These	  experiments	  may	  shed	  light	  on	  any	  loss	  of	  iron	  that	  occurs	  simply	  as	  an	  effect	  of	  the	  symptoms	  of	  CF.	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A	   common	   technique	   use	   to	   measure	   DNA	   fragmentation	   resulting	   from	  apoptotic	   signaling	   cascades	   is	   the	   dUTP	   nick	   end	   labeling	   (TUNEL)	   assay.	   The	  TUNEL	  assay	  employs	  a	  terminal	  deoxynucleotidyl	  transferase	  that	  can	  incorporate	  fluorescently	   labeled	   nucleotides	   onto	   fragmented	   DNA,	   indicating	   apoptosis	   or	  necrosis.	  Attempts	  to	  utilize	  a	  whole	  mount	  TUNEL	  assay	  to	  measure	  ETA	  induced	  apoptosis	   and	   necrosis	   were	   unsuccessful.	   This	   was	   probably	   a	   result	   of	   the	  relatively	   low	   inoculum	   size	   and	  because	   the	   disseminated	   infection	   that	   resulted	  from	   directly	   introducing	   the	   bacteria	   into	   the	   bloodstream	   may	   cause	   some	  cytotoxicity	   spread	   throughout	   the	   fish,	  which	  would	   be	   very	   difficult	   to	  measure	  using	  this	  assay.	  It	  may	  be	  possible	  to	  establish	  a	  discrete	  infection,	  similar	  to	  those	  infections	   used	   for	   the	   neutrophil	   migration	   assays,	   and	   measure	   cytotoxicity	   in	  those	   discrete	   areas	   of	   the	   fish.	   If	   these	   assays	   are	   successful,	   they	   are	   a	   good	  indication	  that	  our	  hypothesis	   is	  correct.	  They	  are	  not	  by	  any	  means	  confirmative,	  however,	  because	  as	  discussed	  in	  chapter	  1,	  there	  are	  a	  myriad	  of	  virulence	  factors	  and	   toxins	   produced	   during	   infection	   that	   could	   account	   for	   this	   necrosis	   and	  apoptosis.	  A	   more	   confirmative	   and	   indeed	   more	   quantitative	   approach	   would	   be	   to	  measure	   the	   expression	   levels	   of	   ETA	   and	   other	   iron	   regulated	   virulence	   factors	  during	   infection	   in	   the	   zebrafish	   by	   quantitative	   RT-­‐PCR.	   Total	   RNA	   could	   be	  extracted	   from	   infected	  Cftr	  morphant	   and	   control	   embryos	   and	   the	   relative	   copy	  number	   for	   the	   iron	   regulated	   P.	   aeruginosa	   genes	   could	   be	   measured.	   Other	  techniques,	   including	   whole	   mount	   fluorescence-­‐based	   assays	   using	   a	   probe	   or	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antibody	  specific	  for	  ETA	  could	  also	  potentially	  be	  used	  to	  measure	  the	  expression	  of	  the	  toxin.	  One	  of	   the	  major	  disadvantages	  of	  our	  model	   is	   that	   the	  knockdown	  of	  Cftr	  using	  morpholinos	  (MOs)	  is	  only	  transient	  and	  the	  effects	  of	  the	  MOs	  are	  diluted	  out	  after	   the	   first	  week	  of	   the	   embryos	   life.	   Several	  methods	   for	  developing	  knockout	  mutants	   in	   zebrafish	   have	   become	   popular,	   ENU	   mutagenesis	   and	   tilling	   for	  mutations	  has	  been	  used	  but	  the	  process	  is	  time	  consuming	  and	  technically	  difficult.	  A	  new	   technique	   that	  has	   come	   into	   favor	   recently	   is	   the	  use	  of	   sequence	   specific	  zinc	   finger	   nucelases	   (ZFNs)	   to	   target	   and	  mutate	   genes	   in	   the	   zebrafish.	   A	   novel	  “open-­‐source”	  method	  of	  engineering	  ZFNs	  to	  target	  specific	  genome	  locations	  has	  been	   developed	   and	   the	   new	   ZFNs	   have	   been	   successfully	   used	   to	   modify	   the	  zebrafish	   genome	   (42,	   82,	   83).	  With	   the	   support	   of	   an	  NIH	   grant,	   the	   Zinc	   Finger	  Consortium	  has	  recently	  generated	  customized	  ZFNs	  directed	  against	  the	  zebrafish	  
cftr	  gene.	  These	  ZFNs	  can	  now	  be	  used	  to	  induce	  mutations	  in	  the	  gene	  of	  zebrafish	  and	  could	  ultimately	  enable	  the	  creation	  of	  a	  Cftr	  -­‐/-­‐	  knockout	  mutant	   line.	  Such	  a	  mutant	  could	  be	  extremely	  useful	  for	  studying	  the	  dynamics	  of	  long-­‐term	  infections	  and	   repeated	   exposure	   experiments.	   Another	   potential	   avenue	   for	   future	   studies	  would	   be	   sequential,	   or	   co-­‐infections	  with	  P.	   aeruginosa	   and	   other	   CF	   pathogens.	  Speculation	  has	  recently	  been	  raised	  about	  the	  advantages	  of	  treating	  childhood	  CF	  infections.	  Some	  retrospective	  clinical	  studies	  have	   identified	   that	  children	  treated	  with	  anti-­‐staphylococcal	  antibiotics	  were	  more	   likely	   to	  develop	   infections	  with	  P.	  
aeruginosa	   earlier	   than	   children	   not	   treated	   with	   the	   drugs.	   Because	   multiple	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infections	  would	  be	  challenging	  during	   the	  short	   timeframe	  we	  can	  work	  with	   the	  fish	  now,	  having	  a	  knockout	  line	  at	  our	  disposal	  would	  be	  particularly	  useful.	  When	  taken	  together,	  our	  data	  establish	  the	  value	  of	  our	  new	  CF	  model	  and	  provide	   new	   insights	   into	   the	   pathogenesis	   of	   P.	   aeruginosa	   infection	   in	   humans	  with	   CF.	   The	   advantages	   of	   this	   model	   organism	   make	   these	   infection	   studies	  technically	  easy	  and	  relatively	   inexpensive	   to	  perform.	  Because	   the	  zebrafish	  does	  not	  have	  a	  respiratory	  tract	  that	  is	  homologous	  to	  mammals,	  we	  cannot	  perform	  the	  traditional	   lung	   infection	  experiments.	  This	  may	  not	  necessarily	  be	  a	  disadvantage	  here	   though,	   as	  we	   can	   investigate	   the	  molecular	  mechanisms	   of	   susceptibility	   to	  bacterial	  infections	  in	  CF	  without	  the	  added	  complications	  of	  particular	  anatomical	  structures.	   	   Our	   findings	   highlight	   the	   advantages	   of	   the	   zebrafish	   embryo	   for	  infection	  studies	  and	  provide	  exciting	  avenues	  for	  future	  research.	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  Table	  A.10.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΔLasR	  	  
	  Table	  A.11.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΩLasA	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  Table	  A.12.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΩLasB	  	  
	  Table	  A.13.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΩHplS	  	  




Table	  A.15.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΩRhlA	  	  
	  Table	  A.16.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΩPhzM	  	  
	  Table	  A.17.	  Raw	  plate	  count	  data	  for	  embryos	  infected	  with	  PA14	  ΩToxA	  




Raw	  Respiratory	  Burst	  Assay	  Data	  













Raw	  Neutrophil	  Migration	  Data	  
Table	  C.1.	  Raw	  Neutrophil	  migration	  numbers	  per	  embryo	  at	  3	  hpi	  

















Raw	  Ferrozine	  Assay	  Data	  
Table D.1. Raw ferrozine assay A550 absorbance data (for each embryo) 
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